{
  "protocolId": "NCT02264990_M14-359",
  "version": "1.0",
  "generatedAt": "2025-12-17T23:07:46.651267",
  "therapeuticArea": null,
  "summary": {
    "totalQEBs": 25,
    "inclusionQEBs": 13,
    "exclusionQEBs": 12,
    "fullyQueryable": 6,
    "partiallyQueryable": 11,
    "requiresManualReview": 8,
    "totalAtomicsConsolidated": 88,
    "uniqueOmopConcepts": 87,
    "deduplicationRate": 0.011363636363636354,
    "killerCriteriaCount": 1,
    "funnelStagesCount": 7,
    "eligibilitySectionPages": {
      "start": 33,
      "end": 37
    }
  },
  "funnelStages": [
    {
      "stageId": "FS_1",
      "stageName": "NSCLC Indication & Molecular Profile",
      "stageOrder": 1,
      "qebIds": [
        "QEB_INC_3",
        "QEB_INC_4",
        "QEB_EXC_4"
      ],
      "combinedEliminationRate": 99.8,
      "stageDescription": "Confirms the primary diagnosis of advanced, non-squamous NSCLC without targetable mutations, which is the most restrictive criterion."
    },
    {
      "stageId": "FS_2",
      "stageName": "Prior Anti-Cancer Therapy Review",
      "stageOrder": 2,
      "qebIds": [
        "QEB_EXC_6",
        "QEB_EXC_8",
        "QEB_EXC_11",
        "QEB_EXC_12"
      ],
      "combinedEliminationRate": null,
      "stageDescription": "Evaluates the patient's treatment history to ensure they meet the trial's line of therapy requirements."
    },
    {
      "stageId": "FS_3",
      "stageName": "Performance Status & Disease Burden",
      "stageOrder": 3,
      "qebIds": [
        "QEB_INC_9",
        "QEB_INC_2",
        "QEB_INC_6",
        "QEB_INC_8"
      ],
      "combinedEliminationRate": null,
      "stageDescription": "Assesses the patient's overall fitness, life expectancy, and extent of disease, including CNS involvement and measurability."
    },
    {
      "stageId": "FS_4",
      "stageName": "Baseline Demographics & Medical History",
      "stageOrder": 4,
      "qebIds": [
        "QEB_INC_1",
        "QEB_INC_5",
        "QEB_EXC_5"
      ],
      "combinedEliminationRate": null,
      "stageDescription": "Verifies fundamental patient characteristics and history that could impact eligibility."
    },
    {
      "stageId": "FS_5",
      "stageName": "Comorbidities & Contraindications Assessment",
      "stageOrder": 5,
      "qebIds": [
        "QEB_EXC_1",
        "QEB_EXC_2",
        "QEB_EXC_3",
        "QEB_INC_10"
      ],
      "combinedEliminationRate": null,
      "stageDescription": "Screens for specific pre-existing conditions and known hypersensitivities that would pose a safety risk."
    },
    {
      "stageId": "FS_6",
      "stageName": "Screening Laboratory & Tissue Requirements",
      "stageOrder": 6,
      "qebIds": [
        "QEB_INC_11",
        "QEB_INC_7"
      ],
      "combinedEliminationRate": null,
      "stageDescription": "Confirms adequate organ function via lab tests and ensures consent for mandatory tissue sample provision."
    },
    {
      "stageId": "FS_7",
      "stageName": "Consent & Study Compliance Confirmation",
      "stageOrder": 7,
      "qebIds": [
        "QEB_INC_13",
        "QEB_INC_12",
        "QEB_EXC_10",
        "QEB_EXC_7",
        "QEB_EXC_9"
      ],
      "combinedEliminationRate": null,
      "stageDescription": "Final verification of patient's ability to consent, comply with study procedures, and meet reproductive health requirements."
    }
  ],
  "queryableBlocks": [
    {
      "qebId": "QEB_INC_1",
      "originalCriterionId": "INC_1",
      "criterionType": "inclusion",
      "clinicalName": "Minimum Age of 18 Years",
      "clinicalDescription": "The patient must be 18 years of age or older to enroll in the study.",
      "clinicalCategory": "Demographics",
      "funnelStage": "Baseline Demographics & Medical History",
      "funnelStageOrder": 4,
      "combinedSql": "SELECT DISTINCT person_id FROM person WHERE EXTRACT(YEAR FROM AGE(CURRENT_DATE, birth_datetime)) >= 18",
      "sqlLogicExplanation": "A0001",
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0001"
      ],
      "atomicCount": 1,
      "internalLogic": "SIMPLE",
      "omopConcepts": [
        {
          "conceptId": 4265453,
          "conceptName": "Age",
          "domain": "Observation",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|30525-0"
          },
          "description": null
        }
      ],
      "protocolText": "Subject must be ≥ 18 years of age.",
      "provenance": {
        "pageNumber": 33,
        "sectionId": null,
        "textSnippet": "eligibility based on the most recent data collected prior to randomization.\n5.2.1 Inclusion Criteria\n1. Subject must be ≥ 18 years of age.\n2. Life expectancy > 12 weeks (as per Investigator's clinical assessment)."
      }
    },
    {
      "qebId": "QEB_INC_2",
      "originalCriterionId": "INC_2",
      "criterionType": "inclusion",
      "clinicalName": "Life Expectancy Greater Than 12 Weeks",
      "clinicalDescription": "The investigator must assess that the patient is expected to live for more than 12 weeks.",
      "clinicalCategory": "Prognosis",
      "funnelStage": "Performance Status & Disease Burden",
      "funnelStageOrder": 3,
      "combinedSql": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (3050013) AND value_as_number > 12",
      "sqlLogicExplanation": "A0002",
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "Requires a subjective clinical prognosis ('Investigator's clinical assessment') made at the time of screening, which is not a structured, queryable EHR data point.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0002"
      ],
      "atomicCount": 1,
      "internalLogic": "SIMPLE",
      "omopConcepts": [
        {
          "conceptId": 3050013,
          "conceptName": "Life expectancy [OASIS]",
          "domain": "Observation",
          "vocabularyId": "LOINC",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|46525-2"
          },
          "description": null
        }
      ],
      "protocolText": "Life expectancy > 12 weeks (as per Investigator's clinical assessment).",
      "provenance": {
        "pageNumber": 33,
        "sectionId": null,
        "textSnippet": "5.2.1 Inclusion Criteria\n1. Subject must be ≥ 18 years of age.\n2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC."
      }
    },
    {
      "qebId": "QEB_INC_3",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "clinicalName": "Confirmed Advanced or Metastatic Non-Squamous NSCLC",
      "clinicalDescription": "The patient must have a confirmed diagnosis of advanced or metastatic non-squamous non-small cell lung cancer.",
      "clinicalCategory": "Disease Indication",
      "funnelStage": "NSCLC Indication & Molecular Profile",
      "funnelStageOrder": 1,
      "combinedSql": "(SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276) INTERSECT ((SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION ((SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (4110591, 4115276, 37166577, 37109576, 36684857))))) INTERSECT (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276) INTERSECT (((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444)) UNION (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444)) UNION (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (21492143)))) UNION ((SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (4168352))))",
      "sqlLogicExplanation": "A0003 AND (A0004 OR A0005 AND A0006 AND NOT (A0007)) AND A0008 AND (NOT ((A0009 OR A0010 OR A0011)) OR A0012 AND A0013)",
      "queryableStatus": "partially_queryable",
      "nonQueryableReason": "Requires review of unstructured pathology reports to confirm specific histology (non-squamous), rule out small cell components, assess predominance in mixed tumors, and verify report availability. Diagnosis codes alone are insufficient for this level of detail.",
      "estimatedEliminationRate": 99.8,
      "isKillerCriterion": true,
      "epidemiologicalEvidence": "The 5-year limited-duration prevalence of lung cancer in the US was estimated at 656,330 in 2020 (NCI SEER Cancer Stat Facts: Lung and Bronchus Cancer), representing ~0.2% of the general population.",
      "atomicIds": [
        "A0003",
        "A0004",
        "A0005",
        "A0006",
        "A0007",
        "A0008",
        "A0009",
        "A0010",
        "A0011",
        "A0012",
        "A0013"
      ],
      "atomicCount": 11,
      "internalLogic": "COMPLEX",
      "omopConcepts": [
        {
          "conceptId": 4115276,
          "conceptName": "Non-small cell lung cancer",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 4110591,
          "conceptName": "Small cell carcinoma of lung",
          "domain": "Observation",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 37166577,
          "conceptName": "Primary non-small cell lung cancer",
          "domain": "Observation",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 37109576,
          "conceptName": "Squamous non-small cell lung cancer",
          "domain": "Observation",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 36684857,
          "conceptName": "Metastatic non-small cell lung cancer",
          "domain": "Observation",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 3014444,
          "conceptName": "EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        },
        {
          "conceptId": 21492143,
          "conceptName": "ALK gene rearrangements [Presence] in Blood or Tissue by FISH",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        },
        {
          "conceptId": 4168352,
          "conceptName": "Tumor progression",
          "domain": "Observation",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|254637007,C34.90"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://snomed.info/sct|254632001,http://snomed.info/sct|254637007,http://snomed.info/sct|1259727001,http://snomed.info/sct|723301009,http://snomed.info/sct|457721000124104"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|50917-9"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|62385-0"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://snomed.info/sct|419835002"
          },
          "description": null
        }
      ],
      "protocolText": "Subject must have cytologically or histologically confirmed advanced or metastatic non-squamous NSCLC. Subjects with mixed histology tumors will be eligible if the tumor is predominant non-squamous histology and does not include tumor with small cell histology. Subjects must have a pathologist's report confirming non-squamous NSCLC available for collection by the sponsor. Subjects with EGFR mutation (exon 19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement must have progressed after first line monotherapy treatment with targeted therapy.",
      "provenance": {
        "pageNumber": 33,
        "sectionId": null,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de..."
      }
    },
    {
      "qebId": "QEB_INC_4",
      "originalCriterionId": "INC_4",
      "criterionType": "inclusion",
      "clinicalName": "NSCLC Not Amenable to Curative Therapy",
      "clinicalDescription": "The patient's lung cancer cannot be treated with surgery or radiation with the goal of a cure.",
      "clinicalCategory": "Disease Stage",
      "funnelStage": "NSCLC Indication & Molecular Profile",
      "funnelStageOrder": 1,
      "combinedSql": "(SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276) INTERSECT (((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276)) UNION ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276)))",
      "sqlLogicExplanation": "A0014 AND (NOT (A0015) OR NOT (A0016))",
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "Determining if a cancer is 'not amenable to surgical resection or radiation with curative intent' is a complex clinical judgment based on staging, imaging, and multidisciplinary assessment, which is not captured in a single structured field.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0014",
        "A0015",
        "A0016"
      ],
      "atomicCount": 3,
      "internalLogic": "COMPLEX",
      "omopConcepts": [
        {
          "conceptId": 4115276,
          "conceptName": "Non-small cell lung cancer",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|254637007,C34.90"
          },
          "description": null
        }
      ],
      "protocolText": "Subject must have NSCLC that is not amenable to surgical resection or radiation with curative intent at time of study Screening.",
      "provenance": {
        "pageNumber": 34,
        "sectionId": null,
        "textSnippet": "gene rearrangement must have progressed after first line monotherapy treatment \nwith targeted therapy.\n4. Subject must have NSCLC that is not amenable to surgical resection or radiation \nwith curative intent at time of study Screening.\n5. Subjects must be current smokers (defined as having > 100 smoking events lifetime \nand having smoked within the past year) or former smokers (defined as having \n> 100 smoking events lifetime and having not smoked within the past year)."
      }
    },
    {
      "qebId": "QEB_INC_5",
      "originalCriterionId": "INC_5",
      "criterionType": "inclusion",
      "clinicalName": "Current or Former Smoking History",
      "clinicalDescription": "The patient must have a history of smoking, either currently or in the past.",
      "clinicalCategory": "Patient History",
      "funnelStage": "Baseline Demographics & Medical History",
      "funnelStageOrder": 4,
      "combinedSql": "(SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (40483697) AND value_as_number > 100) INTERSECT ((SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (40766945)) UNION ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (40766945))))",
      "sqlLogicExplanation": "A0017 AND (A0018 OR NOT (A0019))",
      "queryableStatus": "partially_queryable",
      "nonQueryableReason": "The specific quantitative definition ('> 100 smoking events lifetime') is not consistently captured in structured smoking status fields, which are often categorical (current/former/never) and may require chart review or patient interview for confirmation.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0017",
        "A0018",
        "A0019"
      ],
      "atomicCount": 3,
      "internalLogic": "COMPLEX",
      "omopConcepts": [
        {
          "conceptId": 40483697,
          "conceptName": "Family history of smoking",
          "domain": "Observation",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 40766945,
          "conceptName": "Current smoker",
          "domain": "Observation",
          "vocabularyId": "LOINC",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://snomed.info/sct|443877004"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|64234-8"
          },
          "description": null
        }
      ],
      "protocolText": "Subjects must be current smokers (defined as having > 100 smoking events lifetime and having smoked within the past year) or former smokers (defined as having > 100 smoking events lifetime and having not smoked within the past year).",
      "provenance": {
        "pageNumber": 34,
        "sectionId": null,
        "textSnippet": "with curative intent at time of study Screening.\n5. Subjects must be current smokers (defined as having > 100 smoking events lifetime \nand having smoked within the past year) or former smokers (defined as having \n> 100 smoking events lifetime and having not smoked within the past year).\n6. Subject must have at least 1 unidimensional measurable NSCLC lesion on a \nCT scan as defined by RECIST (version 1.1)."
      }
    },
    {
      "qebId": "QEB_INC_6",
      "originalCriterionId": "INC_6",
      "criterionType": "inclusion",
      "clinicalName": "Measurable Disease by RECIST 1.1",
      "clinicalDescription": "The patient must have at least one tumor that can be accurately measured on a CT scan per RECIST 1.1 criteria.",
      "clinicalCategory": "Disease Assessment",
      "funnelStage": "Performance Status & Disease Burden",
      "funnelStageOrder": 3,
      "combinedSql": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
      "sqlLogicExplanation": "A0020",
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "Requires manual review and measurement of lesions on imaging scans according to specific RECIST 1.1 guidelines. This is an interpretation of unstructured imaging data performed at screening.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0020"
      ],
      "atomicCount": 1,
      "internalLogic": "SIMPLE",
      "omopConcepts": [
        {
          "conceptId": 4115276,
          "conceptName": "Non-small cell lung cancer",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|254637007,C34.90"
          },
          "description": null
        }
      ],
      "protocolText": "Subject must have at least 1 unidimensional measurable NSCLC lesion on a CT scan as defined by RECIST (version 1.1).",
      "provenance": {
        "pageNumber": 34,
        "sectionId": null,
        "textSnippet": "and having not smoked within the past year).\n6. Subject must have at least 1 unidimensional measurable NSCLC lesion on a \nCT scan as defined by RECIST (version 1.1).\n7. Subject must consent to provide archived tissue or cytology sample of NSCLC \nlesion (primary or metastatic) for analysis if available."
      }
    },
    {
      "qebId": "QEB_INC_7",
      "originalCriterionId": "INC_7",
      "criterionType": "inclusion",
      "clinicalName": "Consent for Tumor Tissue Sample Provision",
      "clinicalDescription": "The patient must agree to provide a previously collected tumor tissue sample for analysis if one is available.",
      "clinicalCategory": "Biomarker/Sample Collection",
      "funnelStage": "Screening Laboratory & Tissue Requirements",
      "funnelStageOrder": 6,
      "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276))) UNION (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (44786487))",
      "sqlLogicExplanation": "(NOT ((A0021 OR A0022)) OR A0023)",
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "Criterion is based on a patient's willingness to consent and the availability of a tissue sample, which are determined at the time of screening and cannot be queried from historical EHR data.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0021",
        "A0022",
        "A0023"
      ],
      "atomicCount": 3,
      "internalLogic": "COMPLEX",
      "omopConcepts": [
        {
          "conceptId": 4115276,
          "conceptName": "Non-small cell lung cancer",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 44786487,
          "conceptName": "Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reas...",
          "domain": "Observation",
          "vocabularyId": "HCPCS",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|254637007,C34.90"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets|G9282"
          },
          "description": null
        }
      ],
      "protocolText": "Subject must consent to provide archived tissue or cytology sample of NSCLC lesion (primary or metastatic) for analysis if available.",
      "provenance": {
        "pageNumber": 34,
        "sectionId": null,
        "textSnippet": "CT scan as defined by RECIST (version 1.1).\n7. Subject must consent to provide archived tissue or cytology sample of NSCLC \nlesion (primary or metastatic) for analysis if available.\n8. Subject must have no history of brain metastases or evidence of CNS tumors at \nscreening assessment. Subjects with signs or symptoms of CNS involvement will \nundergo MRI (or CT scan if MRI is contraindicated) to confirm absence of CNS \nmetastases."
      }
    },
    {
      "qebId": "QEB_INC_8",
      "originalCriterionId": "INC_8",
      "criterionType": "inclusion",
      "clinicalName": "Absence of Brain Metastases or CNS Tumors",
      "clinicalDescription": "The patient must not have any cancer that has spread to the brain or central nervous system.",
      "clinicalCategory": "Disease Extent",
      "funnelStage": "Performance Status & Disease Burden",
      "funnelStageOrder": 3,
      "combinedSql": "((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36768862)) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (3654328, 4082164, 4086181, 4318660, 4134439)))",
      "sqlLogicExplanation": "NOT (A0024) AND NOT (A0025)",
      "queryableStatus": "partially_queryable",
      "nonQueryableReason": "Confirming the absence of a condition is difficult. While diagnosis codes for brain metastases can be queried, definitive exclusion requires review of recent, often unstructured, brain imaging reports (MRI/CT).",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0024",
        "A0025"
      ],
      "atomicCount": 2,
      "internalLogic": "COMPLEX",
      "omopConcepts": [
        {
          "conceptId": 36768862,
          "conceptName": "Metastasis to brain",
          "domain": "Measurement",
          "vocabularyId": "Cancer Modifier",
          "conceptCode": null
        },
        {
          "conceptId": 3654328,
          "conceptName": "Normal central nervous system",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 4082164,
          "conceptName": "Cyst of central nervous system",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4086181,
          "conceptName": "Central nervous system finding",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4318660,
          "conceptName": "Central nervous system deficit",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4134439,
          "conceptName": "Injury of central nervous system",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://hl7.org/fhir/sid/icd-10-cm|C79.31"
          },
          "description": null
        },
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|830121005,http://snomed.info/sct|277333006,http://snomed.info/sct|246556002,http://snomed.info/sct|220363002,http://snomed.info/sct|128126004"
          },
          "description": null
        }
      ],
      "protocolText": "Subject must have no history of brain metastases or evidence of CNS tumors at screening assessment. Subjects with signs or symptoms of CNS involvement will undergo MRI (or CT scan if MRI is contraindicated) to confirm absence of CNS metastases.",
      "provenance": {
        "pageNumber": 34,
        "sectionId": null,
        "textSnippet": "lesion (primary or metastatic) for analysis if available.\n8. Subject must have no history of brain metastases or evidence of CNS tumors at \nscreening assessment. Subjects with signs or symptoms of CNS involvement will \nundergo MRI (or CT scan if MRI is contraindicated) to confirm absence of CNS \nmetastases.\n9. Subject must have an Eastern Cooperative Oncology Group (ECOG) Performance \nScore of 0 – 1."
      }
    },
    {
      "qebId": "QEB_INC_9",
      "originalCriterionId": "INC_9",
      "criterionType": "inclusion",
      "clinicalName": "ECOG Performance Status of 0 or 1",
      "clinicalDescription": "The patient must be fully active or have only minor restrictions in their daily activities.",
      "clinicalCategory": "Functional Status",
      "funnelStage": "Performance Status & Disease Burden",
      "funnelStageOrder": 3,
      "combinedSql": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36305384 AND 0-1",
      "sqlLogicExplanation": "A0026",
      "queryableStatus": "partially_queryable",
      "nonQueryableReason": "ECOG status is a subjective clinical assessment that must be performed at screening. Historical values in the EHR may be outdated, inconsistently recorded, or not reflect the patient's current condition.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0026"
      ],
      "atomicCount": 1,
      "internalLogic": "SIMPLE",
      "omopConcepts": [
        {
          "conceptId": 36305384,
          "conceptName": "ECOG Performance Status score",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|89247-1"
          },
          "description": null
        }
      ],
      "protocolText": "Subject must have an Eastern Cooperative Oncology Group (ECOG) Performance Score of 0 – 1.",
      "provenance": {
        "pageNumber": 34,
        "sectionId": null,
        "textSnippet": "undergo MRI (or CT scan if MRI is contraindicated) to confirm absence of CNS \nmetastases.\n9. Subject must have an Eastern Cooperative Oncology Group (ECOG) Performance \nScore of 0 – 1.\n10. Subjects with fluid retention, including ascites or pleural effusion, may be allowed \nat the discretion of the Investigator."
      }
    },
    {
      "qebId": "QEB_INC_10",
      "originalCriterionId": "INC_10",
      "criterionType": "inclusion",
      "clinicalName": "Fluid Retention Permitted at Investigator Discretion",
      "clinicalDescription": "Patients with fluid buildup, such as in the abdomen or around the lungs, may be included if the investigator agrees.",
      "clinicalCategory": "Comorbid Conditions",
      "funnelStage": "Comorbidities & Contraindications Assessment",
      "funnelStageOrder": 5,
      "combinedSql": "(SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (433595, 44832710, 35207099, 44835763, 4155910)) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (200528)) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (254061))",
      "sqlLogicExplanation": "(A0027 OR A0028 OR A0029)",
      "queryableStatus": "partially_queryable",
      "nonQueryableReason": "While the presence of fluid retention can be queried via diagnosis codes, the key component is 'at the discretion of the Investigator,' which is a subjective judgment and not queryable.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0027",
        "A0028",
        "A0029"
      ],
      "atomicCount": 3,
      "internalLogic": "OR",
      "omopConcepts": [
        {
          "conceptId": 433595,
          "conceptName": "Edema",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 44832710,
          "conceptName": "Edema",
          "domain": "Condition",
          "vocabularyId": "ICD9CM",
          "conceptCode": null
        },
        {
          "conceptId": 35207099,
          "conceptName": "Fluid overload",
          "domain": "Condition",
          "vocabularyId": "ICD10CM",
          "conceptCode": null
        },
        {
          "conceptId": 44835763,
          "conceptName": "Fluid overload",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4155910,
          "conceptName": "Generalized edema",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 200528,
          "conceptName": "Ascites",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 254061,
          "conceptName": "Pleural effusion",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|267038008,http://hl7.org/fhir/sid/icd-9-cm|782.3,http://hl7.org/fhir/sid/icd-10-cm|E87.7,http://snomed.info/sct|21639008,http://hl7.org/fhir/sid/icd-9-cm|276.6,http://snomed.info/sct|271808008"
          },
          "description": null
        },
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|389026000,R18.8"
          },
          "description": null
        },
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|60046008,J91.8"
          },
          "description": null
        }
      ],
      "protocolText": "Subjects with fluid retention, including ascites or pleural effusion, may be allowed at the discretion of the Investigator.",
      "provenance": {
        "pageNumber": 34,
        "sectionId": null,
        "textSnippet": "9. Subject must have an Eastern Cooperative Oncology Group (ECOG) Performance \nScore of 0 – 1.\n10. Subjects with fluid retention, including ascites or pleural effusion, may be allowed \nat the discretion of the Investigator.\n11. Subject must have adequate bone marrow, renal and hepatic function as follows:"
      }
    },
    {
      "qebId": "QEB_INC_11",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "clinicalName": "Adequate Hematologic, Renal, and Hepatic Function",
      "clinicalDescription": "The patient's blood counts, kidney function, and liver function must meet specific laboratory value requirements.",
      "clinicalCategory": "Laboratory Values",
      "funnelStage": "Screening Laboratory & Tissue Requirements",
      "funnelStageOrder": 6,
      "combinedSql": "(SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 1500) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number >= 100000) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3000963 AND value_as_number >= 9.0) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number > 50) INTERSECT ((((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36770544)) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number <= 2.5) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number <= 2.5)) UNION ((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36770544) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number < 5.0) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number < 5.0))) INTERSECT ((((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740))) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number <= 1.5)) UNION ((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740)) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number >= 1.5)))",
      "sqlLogicExplanation": "A0030 AND A0031 AND A0032 AND A0033 AND (NOT (A0034) AND A0035 AND A0036 OR A0037 AND A0038 AND A0039) AND (NOT (A0040) AND A0041 OR A0042 AND A0043)",
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0030",
        "A0031",
        "A0032",
        "A0033",
        "A0034",
        "A0035",
        "A0036",
        "A0037",
        "A0038",
        "A0039",
        "A0040",
        "A0041",
        "A0042",
        "A0043"
      ],
      "atomicCount": 14,
      "internalLogic": "COMPLEX",
      "omopConcepts": [
        {
          "conceptId": 3017732,
          "conceptName": "Neutrophils [#/volume] in Blood",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        },
        {
          "conceptId": 3007461,
          "conceptName": "Platelets [#/volume] in Blood",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        },
        {
          "conceptId": 3000963,
          "conceptName": "Hemoglobin [Mass/volume] in Blood",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        },
        {
          "conceptId": 3016723,
          "conceptName": "Creatinine [Mass/volume] in Serum or Plasma",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        },
        {
          "conceptId": 36770544,
          "conceptName": "Metastasis to liver",
          "domain": "Measurement",
          "vocabularyId": "Cancer Modifier",
          "conceptCode": null
        },
        {
          "conceptId": 3013721,
          "conceptName": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        },
        {
          "conceptId": 3006923,
          "conceptName": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        },
        {
          "conceptId": 4099740,
          "conceptName": "Gilbert's syndrome",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 3024128,
          "conceptName": "Bilirubin.total [Mass/volume] in Serum or Plasma",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|26499-4"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|26515-7"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|718-7"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|2160-0"
          },
          "description": null
        },
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://hl7.org/fhir/sid/icd-10-cm|C78.7"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|1920-8"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|1742-6"
          },
          "description": null
        },
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|27503000,E80.4"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|1975-2"
          },
          "description": null
        }
      ],
      "protocolText": "Subject must have adequate bone marrow, renal and hepatic function as follows:\n\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); Platelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL;\n\n● Renal function: Serum calculated creatinine clearance > 50 mL/min according to the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may be done by a local direct measurement method (e.g., 24 hour urine collection or radioisotope) at the investigator's discretion;\n\n● Hepatic function: AST and ALT ≤ 2.5 × ULN unless liver metastases are present, then AST and ALT < 5.0 × ULN; bilirubin ≤ 1.5 × ULN unless Gilbert's Syndrome is present, then bilirubin ≥ 1.5 × ULN.",
      "provenance": {
        "pageNumber": 34,
        "sectionId": null,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di..."
      }
    },
    {
      "qebId": "QEB_INC_12",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "clinicalName": "Contraception Requirements for Men and Women",
      "clinicalDescription": "Male and female patients who can have children must agree to use effective birth control during and after the study.",
      "clinicalCategory": "Reproductive Health",
      "funnelStage": "Consent & Study Compliance Confirmation",
      "funnelStageOrder": 7,
      "combinedSql": "(((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT person_id FROM person WHERE person_concept_id IN (4015271, 4009882, 4010345, 4010845, 4014457)) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE) UNION (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (42536952, 42536960, 42536954, 42537021, 4117038)) UNION (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (43531553, 4297990, 43021519)) UNION (SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (4127886, 4023403, 4021530)))))) UNION (-- TEMPORAL NODE WITHOUT OPERAND)) INTERSECT (((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT person_id FROM person WHERE person_concept_id IN (4135840, 4015423, 4198781, 4015271, 4140373)) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (4330583, 4163273, 4170966, 4072179)) UNION (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957))))) UNION (-- TEMPORAL NODE WITHOUT OPERAND))",
      "sqlLogicExplanation": "(NOT (A0044 AND NOT ((A0045 OR A0046 OR A0047 OR A0048))) OR ) AND (NOT (A0049 AND NOT ((A0050 OR A0051))) OR )",
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "Requires a patient interview to determine childbearing potential and confirm willingness and ability to comply with specified contraception methods. This information is not contained in historical EHR data.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0044",
        "A0045",
        "A0046",
        "A0047",
        "A0048",
        "A0049",
        "A0050",
        "A0051"
      ],
      "atomicCount": 8,
      "internalLogic": "COMPLEX",
      "omopConcepts": [
        {
          "conceptId": 4015271,
          "conceptName": "Baby female",
          "domain": "Person",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 4009882,
          "conceptName": "Well female child",
          "domain": "Person",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4010345,
          "conceptName": "Well female adult",
          "domain": "Person",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4010845,
          "conceptName": "Well female elder",
          "domain": "Person",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4014457,
          "conceptName": "Two female babies",
          "domain": "Person",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 42536952,
          "conceptName": "Elective upper segment cesarean section with bilateral tubal ligation",
          "domain": "Procedure",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 42536960,
          "conceptName": "Elective lower segment cesarean section with bilateral tubal ligation",
          "domain": "Procedure",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 42536954,
          "conceptName": "Emergency upper segment cesarean section with bilateral tubal ligation",
          "domain": "Procedure",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 42537021,
          "conceptName": "Emergency lower segment cesarean section with bilateral tubal ligation",
          "domain": "Procedure",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4117038,
          "conceptName": "Ligation of bilateral fallopian tubes",
          "domain": "Procedure",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 43531553,
          "conceptName": "Laparoscopic bilateral oophorectomy",
          "domain": "Procedure",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 4297990,
          "conceptName": "Excision of bilateral ovaries",
          "domain": "Procedure",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 43021519,
          "conceptName": "Excision of bilateral ovaries for malignant neoplasm of ovary",
          "domain": "Procedure",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4127886,
          "conceptName": "Hysterectomy",
          "domain": "Procedure",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 4023403,
          "conceptName": "Total hysterectomy",
          "domain": "Procedure",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4021530,
          "conceptName": "Radical hysterectomy",
          "domain": "Procedure",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4135840,
          "conceptName": "Maleo",
          "domain": "Person",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 4015423,
          "conceptName": "Baby male",
          "domain": "Person",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4198781,
          "conceptName": "Thermales",
          "domain": "Person",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4140373,
          "conceptName": "Feminized male",
          "domain": "Person",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4330583,
          "conceptName": "Vasectomy",
          "domain": "Procedure",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 4163273,
          "conceptName": "Male sterilization",
          "domain": "Procedure",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4170966,
          "conceptName": "Ligation vasectomy",
          "domain": "Procedure",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4072179,
          "conceptName": "Reversal of vasectomy",
          "domain": "Procedure",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 42528957,
          "conceptName": "Pregnancy status",
          "domain": "Observation",
          "vocabularyId": "LOINC",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Patient",
          "searchParams": {
            "query": "identifier=http://snomed.info/sct|169839008,http://snomed.info/sct|102508009,http://snomed.info/sct|102514002,http://snomed.info/sct|102517009,http://snomed.info/sct|169841009"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://snomed.info/sct|169839008,http://snomed.info/sct|102508009,http://snomed.info/sct|102514002,http://snomed.info/sct|102517009,http://snomed.info/sct|169841009"
          },
          "description": null
        },
        {
          "resourceType": "Procedure",
          "searchParams": {
            "query": "code=http://snomed.info/sct|736018001,http://snomed.info/sct|736026009,http://snomed.info/sct|736020003,http://snomed.info/sct|736118004,http://snomed.info/sct|287664005"
          },
          "description": null
        },
        {
          "resourceType": "Procedure",
          "searchParams": {
            "query": "code=http://snomed.info/sct|609275002,http://snomed.info/sct|76876009,http://snomed.info/sct|473239006"
          },
          "description": null
        },
        {
          "resourceType": "Procedure",
          "searchParams": {
            "query": "code=http://snomed.info/sct|236886002,http://snomed.info/sct|116140006,http://snomed.info/sct|116142003"
          },
          "description": null
        },
        {
          "resourceType": "Patient",
          "searchParams": {
            "query": "identifier=http://snomed.info/sct|31792003,http://snomed.info/sct|169838000,http://snomed.info/sct|433198003,http://snomed.info/sct|169839008,http://snomed.info/sct|32951002"
          },
          "description": null
        },
        {
          "resourceType": "Procedure",
          "searchParams": {
            "query": "code=http://snomed.info/sct|22523008,http://snomed.info/sct|399141000,http://snomed.info/sct|276486001,http://snomed.info/sct|176490000"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|82810-3,77386006"
          },
          "description": null
        }
      ],
      "protocolText": "Female subjects of childbearing potential (i.e., those who are not postmenopausal for at least 1 year or surgically sterile by bilateral tubal ligation, bilateral oophorectomy or hysterectomy) and their male partners should practice at least one of the methods of birth control listed below during study and for at least 6 months after treatment with paclitaxel chemotherapy. Male subjects and their female partners of childbearing potential should practice at least one of the methods of birth control listed below during study and for at least 6 months after treatment with chemotherapy.\n\n● total abstinence from sexual intercourse (if it is the subject's preferred and usual lifestyle; for beginning a minimum one complete menstrual cycle prior to study drug administration and to extend 6 months after treatment);\n\n● vasectomized subject or partner(s); vasectomy (males);\n\n● intrauterine device (females);\n\n● double-barrier method (condoms, contraceptive sponge, diaphragm or vaginal ring with spermicidal jellies or creams; both males and females);\n\n● hormonal contraceptives (oral, parenteral or transdermal) for at least 90 days prior to study drug administration (females). If hormonal contraceptives are used, the subject and her partner should also use a single-barrier method.",
      "provenance": {
        "pageNumber": 35,
        "sectionId": null,
        "textSnippet": "Gilbert's Syndrome is present, then bilirubin ≥ 1.5 × ULN.\n12. Female subjects of childbearing potential (i.e., those who are not postmenopausal \nfor at least 1 year or surgically sterile by bilateral tubal ligation, bilateral \noophorectomy or hysterectomy) and their male partners should practice at least one \nof the methods of birth control listed below during study and for at least 6 months \nafter treatment with paclitaxel chemotherapy. Male subjects and their female \npartners of childbeari..."
      }
    },
    {
      "qebId": "QEB_INC_13",
      "originalCriterionId": "INC_13",
      "criterionType": "inclusion",
      "clinicalName": "Ability to Provide Informed Consent and Comply",
      "clinicalDescription": "The patient must be able to understand the study, follow instructions, and sign the consent form.",
      "clinicalCategory": "Study Conduct",
      "funnelStage": "Consent & Study Compliance Confirmation",
      "funnelStageOrder": 7,
      "combinedSql": "(SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) INTERSECT (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (3018196))",
      "sqlLogicExplanation": "A0052 AND A0053 AND A0054",
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "Assesses a patient's cognitive ability, understanding, and willingness to comply with the protocol, which requires direct interaction at screening and cannot be determined from EHR data.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0052",
        "A0053",
        "A0054"
      ],
      "atomicCount": 3,
      "internalLogic": "AND",
      "omopConcepts": [
        {
          "conceptId": 3018196,
          "conceptName": "Informed consent obtained",
          "domain": "Observation",
          "vocabularyId": "LOINC",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|19826-7"
          },
          "description": null
        }
      ],
      "protocolText": "Subject must be capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consent approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures.",
      "provenance": {
        "pageNumber": 35,
        "sectionId": null,
        "textSnippet": "used, the subject and her partner should also use a single-barrier method.\n13. Subject must be capable of understanding and complying with parameters as \noutlined in the protocol and able to sign and date the informed consent approved by \nan Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.\nRationale for Inclusion Criteria"
      }
    },
    {
      "qebId": "QEB_EXC_1",
      "originalCriterionId": "EXC_1",
      "criterionType": "exclusion",
      "clinicalName": "Known Hypersensitivity to Paclitaxel or Excipients",
      "clinicalDescription": "Patients with a known allergy to paclitaxel or its formulation ingredients are not eligible.",
      "clinicalCategory": "Contraindications",
      "funnelStage": "Comorbidities & Contraindications Assessment",
      "funnelStageOrder": 5,
      "combinedSql": "(SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4273629)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
      "sqlLogicExplanation": "(A0055 OR A0056)",
      "queryableStatus": "partially_queryable",
      "nonQueryableReason": "Structured allergy lists in EHRs may be incomplete or inaccurate. Confirmation often requires a patient interview. Specific allergies to excipients like Cremophor are rarely documented in a structured format.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0055",
        "A0056"
      ],
      "atomicCount": 2,
      "internalLogic": "OR",
      "omopConcepts": [
        {
          "conceptId": 4273629,
          "conceptName": "Chemotherapy",
          "domain": "Procedure",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Procedure",
          "searchParams": {
            "query": "code=http://snomed.info/sct|367336001"
          },
          "description": null
        }
      ],
      "protocolText": "Subject has a known hypersensitivity to paclitaxel or to other drugs formulated with polyethoxylated castor oil (Cremophor).",
      "provenance": {
        "pageNumber": 36,
        "sectionId": null,
        "textSnippet": "(13) This is standard criteria in accordance with harmonized Good Clinical Practice.\n5.2.2 Exclusion Criteria\n1. Subject has a known hypersensitivity to paclitaxel or to other drugs formulated \nwith polyethoxylated castor oil (Cremophor).\n2. Subject has a known hypersensitivity to platinum compounds."
      }
    },
    {
      "qebId": "QEB_EXC_2",
      "originalCriterionId": "EXC_2",
      "criterionType": "exclusion",
      "clinicalName": "Known Hypersensitivity to Platinum Compounds",
      "clinicalDescription": "Patients with a known allergy to platinum-based chemotherapy drugs are not eligible.",
      "clinicalCategory": "Contraindications",
      "funnelStage": "Comorbidities & Contraindications Assessment",
      "funnelStageOrder": 5,
      "combinedSql": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
      "sqlLogicExplanation": "A0057",
      "queryableStatus": "partially_queryable",
      "nonQueryableReason": "Structured allergy lists in EHRs may be incomplete or inaccurate. Confirmation of a 'known' hypersensitivity often requires a patient interview.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0057"
      ],
      "atomicCount": 1,
      "internalLogic": "SIMPLE",
      "omopConcepts": [],
      "fhirResources": [],
      "protocolText": "Subject has a known hypersensitivity to platinum compounds.",
      "provenance": {
        "pageNumber": 36,
        "sectionId": null,
        "textSnippet": "1. Subject has a known hypersensitivity to paclitaxel or to other drugs formulated \nwith polyethoxylated castor oil (Cremophor).\n2. Subject has a known hypersensitivity to platinum compounds.\n3. Subjects with peripheral neuropathy ≥ grade 2."
      }
    },
    {
      "qebId": "QEB_EXC_3",
      "originalCriterionId": "EXC_3",
      "criterionType": "exclusion",
      "clinicalName": "Significant Pre-existing Peripheral Neuropathy",
      "clinicalDescription": "Patients with moderate to severe nerve damage (neuropathy) in their hands or feet are excluded.",
      "clinicalCategory": "Comorbid Conditions",
      "funnelStage": "Comorbidities & Contraindications Assessment",
      "funnelStageOrder": 5,
      "combinedSql": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4117779)",
      "sqlLogicExplanation": "A0058",
      "queryableStatus": "partially_queryable",
      "nonQueryableReason": "While a diagnosis of peripheral neuropathy can be queried, the specific grade (≥ grade 2) is a clinical assessment (e.g., using CTCAE criteria) that is typically documented in unstructured clinical notes, not as a structured field.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0058"
      ],
      "atomicCount": 1,
      "internalLogic": "SIMPLE",
      "omopConcepts": [
        {
          "conceptId": 4117779,
          "conceptName": "Peripheral nerve disease",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|302226006,G62.9"
          },
          "description": null
        }
      ],
      "protocolText": "Subjects with peripheral neuropathy ≥ grade 2.",
      "provenance": {
        "pageNumber": 36,
        "sectionId": null,
        "textSnippet": "2. Subject has a known hypersensitivity to platinum compounds.\n3. Subjects with peripheral neuropathy ≥ grade 2.\n4. Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon \n19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. \nSubjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry."
      }
    },
    {
      "qebId": "QEB_EXC_4",
      "originalCriterionId": "EXC_4",
      "criterionType": "exclusion",
      "clinicalName": "Exclusion of Squamous NSCLC or Untreated Driver Mutations",
      "clinicalDescription": "Patients with squamous lung cancer or untreated EGFR/ALK mutations are not eligible for this study.",
      "clinicalCategory": "Disease Indication",
      "funnelStage": "NSCLC Indication & Molecular Profile",
      "funnelStageOrder": 1,
      "combinedSql": "((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276) UNION (((SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444)) UNION (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444))) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444)))) UNION (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (21492143))) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444)) INTERSECT (SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (21492143))",
      "sqlLogicExplanation": "(A0059 OR (A0060 OR A0061) AND NOT (A0062) OR A0063) AND A0064 AND A0065",
      "queryableStatus": "partially_queryable",
      "nonQueryableReason": "Requires linking specific histology from pathology reports with genomic test results (which may be in unstructured PDFs) and treatment history to confirm 'untreated' status. The requirement that status 'must be known' is a logistical check, not a data query.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0059",
        "A0060",
        "A0061",
        "A0062",
        "A0063",
        "A0064",
        "A0065"
      ],
      "atomicCount": 7,
      "internalLogic": "COMPLEX",
      "omopConcepts": [
        {
          "conceptId": 4115276,
          "conceptName": "Non-small cell lung cancer",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 3014444,
          "conceptName": "EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        },
        {
          "conceptId": 21492143,
          "conceptName": "ALK gene rearrangements [Presence] in Blood or Tissue by FISH",
          "domain": "Measurement",
          "vocabularyId": "LOINC",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|254637007,C34.90"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|50917-9"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|62385-0"
          },
          "description": null
        }
      ],
      "protocolText": "Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon 19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. Subjects' EGFR mutation and ALK gene rearrangement status must be known prior to study entry.",
      "provenance": {
        "pageNumber": 36,
        "sectionId": null,
        "textSnippet": "3. Subjects with peripheral neuropathy ≥ grade 2.\n4. Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon \n19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. \nSubjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry.\n5. A history of seizure within 12 months prior to study entry."
      }
    },
    {
      "qebId": "QEB_EXC_5",
      "originalCriterionId": "EXC_5",
      "criterionType": "exclusion",
      "clinicalName": "History of Seizure Within 12 Months",
      "clinicalDescription": "Patients who have had a seizure in the last year are not eligible.",
      "clinicalCategory": "Neurological History",
      "funnelStage": "Baseline Demographics & Medical History",
      "funnelStageOrder": 4,
      "combinedSql": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (377091)",
      "sqlLogicExplanation": "A0066",
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0066"
      ],
      "atomicCount": 1,
      "internalLogic": "SIMPLE",
      "omopConcepts": [
        {
          "conceptId": 377091,
          "conceptName": "Seizure",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|91175000,G40.909"
          },
          "description": null
        }
      ],
      "protocolText": "A history of seizure within 12 months prior to study entry.",
      "provenance": {
        "pageNumber": 36,
        "sectionId": null,
        "textSnippet": "Subjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry.\n5. A history of seizure within 12 months prior to study entry.\n6. Subject has received prior cytotoxic chemotherapy or chemoradiotherapy for \nNSCLC, except adjuvant or neoadjuvant therapy > 12 months prior to C1D-2, or \nsubject has received targeted small molecule monotherapy for EGFR and/or \nALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2."
      }
    },
    {
      "qebId": "QEB_EXC_6",
      "originalCriterionId": "EXC_6",
      "criterionType": "exclusion",
      "clinicalName": "Prior Systemic or Radiotherapy for NSCLC",
      "clinicalDescription": "Patients who have received certain prior chemotherapy, targeted therapy, or radiation for their lung cancer are excluded based on specific washout periods.",
      "clinicalCategory": "Prior Therapy",
      "funnelStage": "Prior Anti-Cancer Therapy Review",
      "funnelStageOrder": 2,
      "combinedSql": "((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276) UNION (SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276)) INTERSECT (((SELECT DISTINCT person_id FROM drug_exposure WHERE drug_concept_id IN (44808409)) UNION (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (44808409))) INTERSECT ((SELECT DISTINCT person_id FROM person) EXCEPT ((SELECT DISTINCT person_id FROM drug_exposure WHERE drug_concept_id IN (44808409)) UNION (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (44808409)))))",
      "sqlLogicExplanation": "(A0067 OR A0068) AND (A0069 OR A0070) AND NOT ((A0071 OR A0072))",
      "queryableStatus": "partially_queryable",
      "nonQueryableReason": "Determining the context/intent (e.g., adjuvant vs. metastatic) and precise timing of prior therapies often requires chart review beyond simple medication or procedure queries.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0067",
        "A0068",
        "A0069",
        "A0070",
        "A0071",
        "A0072"
      ],
      "atomicCount": 6,
      "internalLogic": "COMPLEX",
      "omopConcepts": [
        {
          "conceptId": 4115276,
          "conceptName": "Non-small cell lung cancer",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 44808409,
          "conceptName": "Neoadjuvant chemotherapy",
          "domain": "Drug",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|254637007,C34.90"
          },
          "description": null
        },
        {
          "resourceType": "MedicationRequest",
          "searchParams": {
            "query": "code=http://snomed.info/sct|829591000000101"
          },
          "description": null
        }
      ],
      "protocolText": "Subject has received prior cytotoxic chemotherapy or chemoradiotherapy for NSCLC, except adjuvant or neoadjuvant therapy > 12 months prior to C1D-2, or subject has received targeted small molecule monotherapy for EGFR and/or ALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior to C1D-2.",
      "provenance": {
        "pageNumber": 36,
        "sectionId": null,
        "textSnippet": "5. A history of seizure within 12 months prior to study entry.\n6. Subject has received prior cytotoxic chemotherapy or chemoradiotherapy for \nNSCLC, except adjuvant or neoadjuvant therapy > 12 months prior to C1D-2, or \nsubject has received targeted small molecule monotherapy for EGFR and/or \nALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2."
      }
    },
    {
      "qebId": "QEB_EXC_7",
      "originalCriterionId": "EXC_7",
      "criterionType": "exclusion",
      "clinicalName": "Recent Use of Anti-Cancer Herbal Remedies",
      "clinicalDescription": "Patients must not have used anti-cancer herbal or Chinese medicines within 14 days of starting treatment.",
      "clinicalCategory": "Concomitant Medications",
      "funnelStage": "Consent & Study Compliance Confirmation",
      "funnelStageOrder": 7,
      "combinedSql": "(SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
      "sqlLogicExplanation": "(A0073 OR A0074)",
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "Use of herbal remedies and over-the-counter supplements is not systematically captured in structured EHR medication lists. This information must be obtained by patient interview.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0073",
        "A0074"
      ],
      "atomicCount": 2,
      "internalLogic": "SIMPLE",
      "omopConcepts": [],
      "fhirResources": [],
      "protocolText": "Subject has received anti-cancer Chinese medicine or anti-cancer herbal remedies within 14 days prior to C1D-2.",
      "provenance": {
        "pageNumber": 36,
        "sectionId": null,
        "textSnippet": "ALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2.\n7. Subject has received anti-cancer Chinese medicine or anti-cancer herbal remedies \nwithin 14 days prior to C1D-2.\n8. Subject has undergone focal External Beam Radiation Therapy (EBRT) to bone \n≤ 2 weeks prior to C1D-2; or subject has undergone EBRT to larger fields \n(i.e., 100 cm2 to thorax) ≤ 4 weeks prior to C1D-2."
      }
    },
    {
      "qebId": "QEB_EXC_8",
      "originalCriterionId": "EXC_8",
      "criterionType": "exclusion",
      "clinicalName": "Recent External Beam Radiation Therapy",
      "clinicalDescription": "Patients who have recently received radiation therapy are excluded based on the timing and area treated.",
      "clinicalCategory": "Prior Therapy",
      "funnelStage": "Prior Anti-Cancer Therapy Review",
      "funnelStageOrder": 2,
      "combinedSql": "(SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id = 600054592) UNION (SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id = 600054592)",
      "sqlLogicExplanation": "(A0075 OR A0076)",
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0075",
        "A0076"
      ],
      "atomicCount": 2,
      "internalLogic": "OR",
      "omopConcepts": [
        {
          "conceptId": 600054592,
          "conceptName": "Radiation Therapy",
          "domain": "Procedure",
          "vocabularyId": "NCIt_Full",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Procedure",
          "searchParams": {
            "query": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C15313"
          },
          "description": null
        }
      ],
      "protocolText": "Subject has undergone focal External Beam Radiation Therapy (EBRT) to bone ≤ 2 weeks prior to C1D-2; or subject has undergone EBRT to larger fields (i.e., 100 cm² to thorax) ≤ 4 weeks prior to C1D-2.",
      "provenance": {
        "pageNumber": 36,
        "sectionId": null,
        "textSnippet": "7. Subject has received anti-cancer Chinese medicine or anti-cancer herbal remedies \nwithin 14 days prior to C1D-2.\n8. Subject has undergone focal External Beam Radiation Therapy (EBRT) to bone \n≤ 2 weeks prior to C1D-2; or subject has undergone EBRT to larger fields \n(i.e., 100 cm2 to thorax) ≤ 4 weeks prior to C1D-2."
      }
    },
    {
      "qebId": "QEB_EXC_9",
      "originalCriterionId": "EXC_9",
      "criterionType": "exclusion",
      "clinicalName": "Unacceptable Risk per Investigator's Judgment",
      "clinicalDescription": "The investigator can exclude any patient they believe is at high risk for complications from the study.",
      "clinicalCategory": "General Safety",
      "funnelStage": "Consent & Study Compliance Confirmation",
      "funnelStageOrder": 7,
      "combinedSql": "(SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)) UNION (SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */))",
      "sqlLogicExplanation": "(A0077 OR A0078)",
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "The criterion is explicitly based on the subjective 'opinion of the Investigator' and cannot be queried from structured data.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0077",
        "A0078"
      ],
      "atomicCount": 2,
      "internalLogic": "OR",
      "omopConcepts": [],
      "fhirResources": [],
      "protocolText": "Any medical condition, which in the opinion of the Investigator, places the subject at an unacceptably high risk for toxicities, or any subject circumstance which prohibits trial participation according to local law.",
      "provenance": {
        "pageNumber": 37,
        "sectionId": null,
        "textSnippet": "9. Any medical condition, which in the opinion of the Investigator, places the subject \nat an unacceptably high risk for toxicities, or any subject circumstance which \nprohibits trial participation according to local law.\n10. Subject is pregnant or lactating.\n11. Subject has previously been treated with a PARP inhibitor."
      }
    },
    {
      "qebId": "QEB_EXC_10",
      "originalCriterionId": "EXC_10",
      "criterionType": "exclusion",
      "clinicalName": "Pregnancy or Lactation",
      "clinicalDescription": "Patients who are pregnant or breastfeeding are not eligible to participate.",
      "clinicalCategory": "Reproductive Health",
      "funnelStage": "Consent & Study Compliance Confirmation",
      "funnelStageOrder": 7,
      "combinedSql": "(SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957) UNION (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957)",
      "sqlLogicExplanation": "(A0079 OR A0080)",
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0079",
        "A0080"
      ],
      "atomicCount": 2,
      "internalLogic": "OR",
      "omopConcepts": [
        {
          "conceptId": 42528957,
          "conceptName": "Pregnancy status",
          "domain": "Observation",
          "vocabularyId": "LOINC",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://loinc.org|82810-3,77386006"
          },
          "description": null
        }
      ],
      "protocolText": "Subject is pregnant or lactating.",
      "provenance": {
        "pageNumber": 37,
        "sectionId": null,
        "textSnippet": "at an unacceptably high risk for toxicities, or any subject circumstance which \nprohibits trial participation according to local law.\n10. Subject is pregnant or lactating.\n11. Subject has previously been treated with a PARP inhibitor."
      }
    },
    {
      "qebId": "QEB_EXC_11",
      "originalCriterionId": "EXC_11",
      "criterionType": "exclusion",
      "clinicalName": "Prior PARP Inhibitor Treatment",
      "clinicalDescription": "Patients who have ever been treated with a PARP inhibitor drug are excluded.",
      "clinicalCategory": "Prior Therapy",
      "funnelStage": "Prior Anti-Cancer Therapy Review",
      "funnelStageOrder": 2,
      "combinedSql": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (600195086)",
      "sqlLogicExplanation": "A0081",
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0081"
      ],
      "atomicCount": 1,
      "internalLogic": "SIMPLE",
      "omopConcepts": [
        {
          "conceptId": 600195086,
          "conceptName": "Targeted Therapy",
          "domain": "Procedure",
          "vocabularyId": "NCIt_Full",
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Procedure",
          "searchParams": {
            "query": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C93352"
          },
          "description": null
        }
      ],
      "protocolText": "Subject has previously been treated with a PARP inhibitor.",
      "provenance": {
        "pageNumber": 37,
        "sectionId": null,
        "textSnippet": "at an unacceptably high risk for toxicities, or any subject circumstance which \nprohibits trial participation according to local law.\n10. Subject is pregnant or lactating.\n11. Subject has previously been treated with a PARP inhibitor."
      }
    },
    {
      "qebId": "QEB_EXC_12",
      "originalCriterionId": "EXC_12",
      "criterionType": "exclusion",
      "clinicalName": "History of Other Malignancy Within 3 Years",
      "clinicalDescription": "Patients with a history of another cancer in the last 3 years are excluded, with some specific exceptions.",
      "clinicalCategory": "Medical History",
      "funnelStage": "Prior Anti-Cancer Therapy Review",
      "funnelStageOrder": 2,
      "combinedSql": "(SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600055953)) INTERSECT ((SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (198984)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (35206494, 192855)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (4111921, 4295624, 4298026, 4308621, 45547492)) UNION (SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (4112752, 4298740, 37396458, 37399589, 45552253)) UNION ((SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (433435, 1244876, 373732, 4116351, 1567746)) INTERSECT (SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (433435, 1244876, 373732, 4116351, 1567746))))",
      "sqlLogicExplanation": "A0082 AND (A0083 OR A0084 OR A0085 OR A0086 OR A0087 AND A0088)",
      "queryableStatus": "partially_queryable",
      "nonQueryableReason": "The exceptions for specific in situ or 'considered cured' cancers require clinical interpretation and review of pathology reports or clinical notes, which goes beyond simple diagnosis code queries.",
      "estimatedEliminationRate": null,
      "isKillerCriterion": false,
      "epidemiologicalEvidence": null,
      "atomicIds": [
        "A0082",
        "A0083",
        "A0084",
        "A0085",
        "A0086",
        "A0087",
        "A0088"
      ],
      "atomicCount": 7,
      "internalLogic": "COMPLEX",
      "omopConcepts": [
        {
          "conceptId": 600055953,
          "conceptName": "Prior Invasive Malignancy",
          "domain": "Observation",
          "vocabularyId": "NCIt_Full",
          "conceptCode": null
        },
        {
          "conceptId": 198984,
          "conceptName": "Malignant tumor of cervix",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 35206494,
          "conceptName": "Carcinoma in situ of bladder",
          "domain": "Condition",
          "vocabularyId": "ICD10CM",
          "conceptCode": null
        },
        {
          "conceptId": 192855,
          "conceptName": "Carcinoma in situ of urinary bladder",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 4111921,
          "conceptName": "Squamous cell carcinoma of skin",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 4295624,
          "conceptName": "Squamous cell carcinoma of skin of ear",
          "domain": "Condition",
          "vocabularyId": "ICD10CM",
          "conceptCode": null
        },
        {
          "conceptId": 4298026,
          "conceptName": "Squamous cell carcinoma of skin of face",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4308621,
          "conceptName": "Squamous cell carcinoma of skin of neck",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 45547492,
          "conceptName": "Squamous cell carcinoma of skin of lip",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4112752,
          "conceptName": "Basal cell carcinoma of skin",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 4298740,
          "conceptName": "Basal cell carcinoma of skin of lip",
          "domain": "Condition",
          "vocabularyId": "ICD10CM",
          "conceptCode": null
        },
        {
          "conceptId": 37396458,
          "conceptName": "Nodular basal cell carcinoma of skin",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 37399589,
          "conceptName": "Basal cell carcinoma of skin in situ",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 45552253,
          "conceptName": "Basal cell carcinoma of skin of lip",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 433435,
          "conceptName": "Carcinoma in situ",
          "domain": "Condition",
          "vocabularyId": "SNOMED",
          "conceptCode": null
        },
        {
          "conceptId": 1244876,
          "conceptName": "Porocarcinoma in situ",
          "domain": "Condition",
          "vocabularyId": "ICD10CM",
          "conceptCode": null
        },
        {
          "conceptId": 373732,
          "conceptName": "Carcinoma in situ of eye",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 4116351,
          "conceptName": "Carcinoma in situ of ear",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        },
        {
          "conceptId": 1567746,
          "conceptName": "Carcinoma in situ of eye",
          "domain": "Condition",
          "vocabularyId": null,
          "conceptCode": null
        }
      ],
      "fhirResources": [
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C154619"
          },
          "description": null
        },
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|363354003,C53.9"
          },
          "description": null
        },
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://hl7.org/fhir/sid/icd-10-cm|D09.0,http://snomed.info/sct|92546004"
          },
          "description": null
        },
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|254651007,http://snomed.info/sct|403894000,http://snomed.info/sct|403892001,http://snomed.info/sct|423284006,http://hl7.org/fhir/sid/icd-10-cm|C44.02,http://snomed.info/sct|285308002"
          },
          "description": null
        },
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|254701007,http://snomed.info/sct|402819001,http://snomed.info/sct|716274007,http://snomed.info/sct|80071000119103,http://hl7.org/fhir/sid/icd-10-cm|C44.01"
          },
          "description": null
        },
        {
          "resourceType": "Condition",
          "searchParams": {
            "query": "code=http://snomed.info/sct|109355002,http://snomed.info/sct|1293095009,http://snomed.info/sct|92590009,http://snomed.info/sct|255144005,http://hl7.org/fhir/sid/icd-10-cm|D09.2"
          },
          "description": null
        },
        {
          "resourceType": "Observation",
          "searchParams": {
            "query": "code=http://snomed.info/sct|109355002,http://snomed.info/sct|1293095009,http://snomed.info/sct|92590009,http://snomed.info/sct|255144005,http://hl7.org/fhir/sid/icd-10-cm|D09.2"
          },
          "description": null
        }
      ],
      "protocolText": "The subject has a history of another cancer within the past 3 years except cervical cancer in situ, in situ carcinoma of the bladder, squamous or basal cell carcinoma of the skin or another in situ cancer that is considered cured by the Investigator (e.g., in situ prostate cancer).",
      "provenance": {
        "pageNumber": 37,
        "sectionId": null,
        "textSnippet": "11. Subject has previously been treated with a PARP inhibitor.\n12. The subject has a history of another cancer within the past 3 years except cervical \ncancer in situ, in situ carcinoma of the bladder, squamous or basal cell carcinoma \nof the skin or another in situ cancer that is considered cured by the Investigator \n(e.g., in situ prostate cancer)."
      }
    }
  ],
  "executionGuide": {
    "recommendedOrder": [
      "QEB_INC_3",
      "QEB_INC_4",
      "QEB_EXC_4",
      "QEB_EXC_6",
      "QEB_EXC_8",
      "QEB_EXC_11",
      "QEB_EXC_12",
      "QEB_INC_2",
      "QEB_INC_6",
      "QEB_INC_8",
      "QEB_INC_9",
      "QEB_INC_1",
      "QEB_INC_5",
      "QEB_EXC_5",
      "QEB_INC_10",
      "QEB_EXC_1",
      "QEB_EXC_2",
      "QEB_EXC_3",
      "QEB_INC_7",
      "QEB_INC_11",
      "QEB_INC_12",
      "QEB_INC_13",
      "QEB_EXC_7",
      "QEB_EXC_9",
      "QEB_EXC_10"
    ],
    "killerCriteria": [
      "QEB_INC_3"
    ],
    "manualReviewRequired": [
      "QEB_INC_2",
      "QEB_INC_4",
      "QEB_INC_6",
      "QEB_INC_7",
      "QEB_INC_12",
      "QEB_INC_13",
      "QEB_EXC_7",
      "QEB_EXC_9"
    ],
    "executionNotes": "Execute criteria in recommended order for optimal patient elimination. Killer criteria should be prioritized as they eliminate the most patients."
  },
  "atomicCriteria": [
    {
      "atomicId": "A0001",
      "originalCriterionId": "INC_1",
      "criterionType": "inclusion",
      "atomicText": "Age >= 18 years",
      "normalizedText": "Age >= 18 years",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          4265453
        ],
        "conceptNames": [
          "Age"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM person WHERE EXTRACT(YEAR FROM AGE(CURRENT_DATE, birth_datetime)) >= 18",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 18"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "30525-0",
            "display": "Age"
          }
        ],
        "searchParams": "code=http://loinc.org|30525-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_1_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 1
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "eligibility based on the most recent data collected prior to randomization.\n5.2.1 Inclusion Criteria\n1. Subject must be ≥ 18 years of age.\n2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Age is a standard demographic field, directly queryable from structured patient data. OMOP concept is available.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0002",
      "originalCriterionId": "INC_2",
      "criterionType": "inclusion",
      "atomicText": "Life expectancy > 12 weeks",
      "normalizedText": "Life expectancy > 12 weeks",
      "category": "other",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          3050013
        ],
        "conceptNames": [
          "Life expectancy [OASIS]"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (3050013) AND value_as_number > 12",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number > 12"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "46525-2",
            "display": "Life expectancy [OASIS]"
          }
        ],
        "searchParams": "code=http://loinc.org|46525-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_2_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 2
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "5.2.1 Inclusion Criteria\n1. Subject must be ≥ 18 years of age.\n2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Life expectancy is a clinical judgment made by an investigator at the time of screening and cannot be queried from historical structured data.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0003",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "Cytologically or histologically confirmed advanced or metastatic Non-Small Cell Lung Cancer",
      "normalizedText": "Cytologically or histologically confirmed advanced or metastatic Non-Small Cell Lung Cancer",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4115276
        ],
        "conceptNames": [
          "Non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of bronchus or lung"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254637007,C34.90",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_3_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 3
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Non-small cell lung cancer is a standard diagnosis with a valid OMOP concept, queryable from condition or observation domains.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0004",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "Tumor is confirmed non-squamous histology",
      "normalizedText": "Tumor is confirmed non-squamous histology",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_3_1b1",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 4
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped (omopConceptId is null). Per the rules, unmapped criteria default to SCREENING_ONLY.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0005",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "Tumor has mixed histology",
      "normalizedText": "Tumor has mixed histology",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_3_1b2a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 5
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped (omopConceptId is null). Per the rules, unmapped criteria default to SCREENING_ONLY.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0006",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "Tumor is predominant non-squamous histology",
      "normalizedText": "Tumor is predominant non-squamous histology",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_3_1b2b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 6
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped (omopConceptId is null). Per the rules, unmapped criteria default to SCREENING_ONLY.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0007",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "Tumor includes small cell histology",
      "normalizedText": "Tumor includes small cell histology",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          4110591,
          4115276,
          37166577,
          37109576,
          36684857
        ],
        "conceptNames": [
          "Small cell carcinoma of lung",
          "Non-small cell lung cancer",
          "Primary non-small cell lung cancer",
          "Squamous non-small cell lung cancer",
          "Metastatic non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (4110591, 4115276, 37166577, 37109576, 36684857)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254632001",
            "display": "Small cell carcinoma of lung"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "1259727001",
            "display": "Primary non-small cell lung cancer"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "723301009",
            "display": "Squamous non-small cell lung cancer"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "457721000124104",
            "display": "Metastatic non-small cell lung cancer"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254632001,http://snomed.info/sct|254637007,http://snomed.info/sct|1259727001,http://snomed.info/sct|723301009,http://snomed.info/sct|457721000124104",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_3_1b2c1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 7
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Small cell carcinoma of lung is a standard diagnosis with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0008",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "Pathologist's report confirming non-squamous NSCLC available for collection",
      "normalizedText": "Pathologist's report confirming non-squamous NSCLC available for collection",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4115276
        ],
        "conceptNames": [
          "Non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of bronchus or lung"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254637007,C34.90",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_3_2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 8
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Non-small cell lung cancer is a standard diagnosis with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0009",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "EGFR exon 19 deletion mutation",
      "normalizedText": "EGFR exon 19 deletion mutation",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3014444
        ],
        "conceptNames": [
          "EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "50917-9",
            "display": "EGFR gene mutation analysis"
          }
        ],
        "searchParams": "code=http://loinc.org|50917-9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_3_3a1a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 9
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "EGFR gene mutation status is a structured lab result in many modern EHRs, especially for oncology. It has a valid OMOP concept and is considered queryable.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0010",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "EGFR L858R mutation in exon 21",
      "normalizedText": "EGFR L858R mutation in exon 21",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3014444
        ],
        "conceptNames": [
          "EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "50917-9",
            "display": "EGFR gene mutation analysis"
          }
        ],
        "searchParams": "code=http://loinc.org|50917-9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_3_3a1b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 10
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "EGFR gene mutation status is a structured lab result in many modern EHRs, especially for oncology. It has a valid OMOP concept and is considered queryable.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0011",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "ALK gene rearrangement",
      "normalizedText": "ALK gene rearrangement",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          21492143
        ],
        "conceptNames": [
          "ALK gene rearrangements [Presence] in Blood or Tissue by FISH"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (21492143)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "62385-0",
            "display": "ALK gene rearrangement analysis"
          }
        ],
        "searchParams": "code=http://loinc.org|62385-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_3_3a1c",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 11
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "ALK gene rearrangement is a structured lab result in many modern EHRs, especially for oncology. It has a valid OMOP concept and is considered queryable.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0012",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "Received first line monotherapy treatment with targeted therapy",
      "normalizedText": "Received first line monotherapy treatment with targeted therapy",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_3_3b1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 12
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped (omopConceptId is null). Per the rules, unmapped criteria default to SCREENING_ONLY.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0013",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "Disease progression",
      "normalizedText": "Disease progression",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          4168352
        ],
        "conceptNames": [
          "Tumor progression"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (4168352)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "419835002",
            "display": "Tumor progression"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|419835002",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_3_3b2a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 13
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "2. Life expectancy > 12 weeks (as per Investigator's clinical assessment).\n3. Subject must have cytologically or histologically confirmed advanced or metastatic \nnon-squamous NSCLC. Subjects with mixed histology tumors will be eligible if \nthe tumor is predominant non-squamous histology and does not include tumor with \nsmall cell histology. Subjects must have a pathologist's report confirming \nnon-squamous NSCLC available for collection by the sponsor. Subjects with \nEGFR mutation (exon 19 de...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 0.85,
        "reasoning": "Tumor progression is a clinical assessment that often requires interpretation of imaging reports and clinical context, making it difficult to query reliably. It is best confirmed via manual review or at screening.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0014",
      "originalCriterionId": "INC_4",
      "criterionType": "inclusion",
      "atomicText": "Diagnosis of Non-Small Cell Lung Cancer (NSCLC)",
      "normalizedText": "Diagnosis of Non-Small Cell Lung Cancer (NSCLC)",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4115276
        ],
        "conceptNames": [
          "Non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of bronchus or lung"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254637007,C34.90",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_4_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 14
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "gene rearrangement must have progressed after first line monotherapy treatment \nwith targeted therapy.\n4. Subject must have NSCLC that is not amenable to surgical resection or radiation \nwith curative intent at time of study Screening.\n5. Subjects must be current smokers (defined as having > 100 smoking events lifetime \nand having smoked within the past year) or former smokers (defined as having \n> 100 smoking events lifetime and having not smoked within the past year).",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Non-small cell lung cancer is a standard diagnosis with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0015",
      "originalCriterionId": "INC_4",
      "criterionType": "inclusion",
      "atomicText": "NSCLC is amenable to surgical resection with curative intent at time of study Screening",
      "normalizedText": "NSCLC is amenable to surgical resection with curative intent at time of study Screening",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4115276
        ],
        "conceptNames": [
          "Non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of bronchus or lung"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254637007,C34.90",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_4_2a1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 15
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "gene rearrangement must have progressed after first line monotherapy treatment \nwith targeted therapy.\n4. Subject must have NSCLC that is not amenable to surgical resection or radiation \nwith curative intent at time of study Screening.\n5. Subjects must be current smokers (defined as having > 100 smoking events lifetime \nand having smoked within the past year) or former smokers (defined as having \n> 100 smoking events lifetime and having not smoked within the past year).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Non-small cell lung cancer is a standard diagnosis with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0016",
      "originalCriterionId": "INC_4",
      "criterionType": "inclusion",
      "atomicText": "NSCLC is amenable to radiation with curative intent at time of study Screening",
      "normalizedText": "NSCLC is amenable to radiation with curative intent at time of study Screening",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4115276
        ],
        "conceptNames": [
          "Non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of bronchus or lung"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254637007,C34.90",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_4_2b1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 16
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "gene rearrangement must have progressed after first line monotherapy treatment \nwith targeted therapy.\n4. Subject must have NSCLC that is not amenable to surgical resection or radiation \nwith curative intent at time of study Screening.\n5. Subjects must be current smokers (defined as having > 100 smoking events lifetime \nand having smoked within the past year) or former smokers (defined as having \n> 100 smoking events lifetime and having not smoked within the past year).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Non-small cell lung cancer is a standard diagnosis with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0017",
      "originalCriterionId": "INC_5",
      "criterionType": "inclusion",
      "atomicText": "More than 100 lifetime smoking events",
      "normalizedText": "More than 100 lifetime smoking events",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 65.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          40483697
        ],
        "conceptNames": [
          "Family history of smoking"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (40483697) AND value_as_number > 100",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number > 100"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "443877004",
            "display": "Family history of smoking"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|443877004",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 17
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "with curative intent at time of study Screening.\n5. Subjects must be current smokers (defined as having > 100 smoking events lifetime \nand having smoked within the past year) or former smokers (defined as having \n> 100 smoking events lifetime and having not smoked within the past year).\n6. Subject must have at least 1 unidimensional measurable NSCLC lesion on a \nCT scan as defined by RECIST (version 1.1).",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.9,
        "reasoning": "Family history is often captured as structured data in social history sections of the EHR. With a valid OMOP concept, it is queryable.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0018",
      "originalCriterionId": "INC_5",
      "criterionType": "inclusion",
      "atomicText": "Smoked within the past year",
      "normalizedText": "Smoked within the past year",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 65.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          40766945
        ],
        "conceptNames": [
          "Current smoker"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (40766945)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "64234-8",
            "display": "Current smoker"
          }
        ],
        "searchParams": "code=http://loinc.org|64234-8",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5_1b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 18
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "with curative intent at time of study Screening.\n5. Subjects must be current smokers (defined as having > 100 smoking events lifetime \nand having smoked within the past year) or former smokers (defined as having \n> 100 smoking events lifetime and having not smoked within the past year).\n6. Subject must have at least 1 unidimensional measurable NSCLC lesion on a \nCT scan as defined by RECIST (version 1.1).",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "Smoking status is a standard, structured data point in the EHR. With a valid OMOP concept, it is queryable.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0019",
      "originalCriterionId": "INC_5",
      "criterionType": "inclusion",
      "atomicText": "Smoked within the past year",
      "normalizedText": "Smoked within the past year",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 65.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          40766945
        ],
        "conceptNames": [
          "Current smoker"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (40766945)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "64234-8",
            "display": "Current smoker"
          }
        ],
        "searchParams": "code=http://loinc.org|64234-8",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5_2b1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 19
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "with curative intent at time of study Screening.\n5. Subjects must be current smokers (defined as having > 100 smoking events lifetime \nand having smoked within the past year) or former smokers (defined as having \n> 100 smoking events lifetime and having not smoked within the past year).\n6. Subject must have at least 1 unidimensional measurable NSCLC lesion on a \nCT scan as defined by RECIST (version 1.1).",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "Smoking status is a standard, structured data point in the EHR. With a valid OMOP concept, it is queryable.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0020",
      "originalCriterionId": "INC_6",
      "criterionType": "inclusion",
      "atomicText": "Has at least 1 unidimensional measurable NSCLC lesion on a CT scan as defined by RECIST v1.1",
      "normalizedText": "Has at least 1 unidimensional measurable NSCLC lesion on a CT scan as defined by RECIST v1.1",
      "category": "disease_indication",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4115276
        ],
        "conceptNames": [
          "Non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 1"
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of bronchus or lung"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254637007,C34.90",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_6_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 20
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "and having not smoked within the past year).\n6. Subject must have at least 1 unidimensional measurable NSCLC lesion on a \nCT scan as defined by RECIST (version 1.1).\n7. Subject must consent to provide archived tissue or cytology sample of NSCLC \nlesion (primary or metastatic) for analysis if available.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Non-small cell lung cancer is a standard diagnosis with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0021",
      "originalCriterionId": "INC_7",
      "criterionType": "inclusion",
      "atomicText": "Archived tissue sample of NSCLC lesion is available",
      "normalizedText": "Archived tissue sample of NSCLC lesion is available",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4115276
        ],
        "conceptNames": [
          "Non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of bronchus or lung"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254637007,C34.90",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_7_1a1",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 21
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "CT scan as defined by RECIST (version 1.1).\n7. Subject must consent to provide archived tissue or cytology sample of NSCLC \nlesion (primary or metastatic) for analysis if available.\n8. Subject must have no history of brain metastases or evidence of CNS tumors at \nscreening assessment. Subjects with signs or symptoms of CNS involvement will \nundergo MRI (or CT scan if MRI is contraindicated) to confirm absence of CNS \nmetastases.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Non-small cell lung cancer is a standard diagnosis with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0022",
      "originalCriterionId": "INC_7",
      "criterionType": "inclusion",
      "atomicText": "Archived cytology sample of NSCLC lesion is available",
      "normalizedText": "Archived cytology sample of NSCLC lesion is available",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4115276
        ],
        "conceptNames": [
          "Non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of bronchus or lung"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254637007,C34.90",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_7_1a2",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 22
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "CT scan as defined by RECIST (version 1.1).\n7. Subject must consent to provide archived tissue or cytology sample of NSCLC \nlesion (primary or metastatic) for analysis if available.\n8. Subject must have no history of brain metastases or evidence of CNS tumors at \nscreening assessment. Subjects with signs or symptoms of CNS involvement will \nundergo MRI (or CT scan if MRI is contraindicated) to confirm absence of CNS \nmetastases.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Non-small cell lung cancer is a standard diagnosis with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0023",
      "originalCriterionId": "INC_7",
      "criterionType": "inclusion",
      "atomicText": "Subject consents to provide an archived sample for analysis",
      "normalizedText": "Subject consents to provide an archived sample for analysis",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          44786487
        ],
        "conceptNames": [
          "Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reas..."
        ],
        "vocabularyIds": [
          "HCPCS"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (44786487)",
        "sqlExecutable": false
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets",
            "code": "G9282",
            "display": "Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reas..."
          }
        ],
        "searchParams": "code=http://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets|G9282",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_7_2",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 23
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "CT scan as defined by RECIST (version 1.1).\n7. Subject must consent to provide archived tissue or cytology sample of NSCLC \nlesion (primary or metastatic) for analysis if available.\n8. Subject must have no history of brain metastases or evidence of CNS tumors at \nscreening assessment. Subjects with signs or symptoms of CNS involvement will \nundergo MRI (or CT scan if MRI is contraindicated) to confirm absence of CNS \nmetastases.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "SQL template requires manual concept selection",
      "queryabilityClassification": {
        "category": "NOT_APPLICABLE",
        "confidence": 1.0,
        "reasoning": "This criterion relates to the documentation process itself, not a clinical characteristic of the patient. It is an administrative/procedural item.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0024",
      "originalCriterionId": "INC_8",
      "criterionType": "inclusion",
      "atomicText": "History of brain metastases",
      "normalizedText": "History of brain metastases",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          36768862
        ],
        "conceptNames": [
          "Metastasis to brain"
        ],
        "vocabularyIds": [
          "Cancer Modifier"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36768862",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C79.31",
            "display": "Secondary malignant neoplasm of brain"
          }
        ],
        "searchParams": "code=http://hl7.org/fhir/sid/icd-10-cm|C79.31",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_8_1a",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 24
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "lesion (primary or metastatic) for analysis if available.\n8. Subject must have no history of brain metastases or evidence of CNS tumors at \nscreening assessment. Subjects with signs or symptoms of CNS involvement will \nundergo MRI (or CT scan if MRI is contraindicated) to confirm absence of CNS \nmetastases.\n9. Subject must have an Eastern Cooperative Oncology Group (ECOG) Performance \nScore of 0 – 1.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "Metastasis to brain is a diagnosis with a standard code. It can be queried from the condition domain to identify a history of brain metastases.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0025",
      "originalCriterionId": "INC_8",
      "criterionType": "inclusion",
      "atomicText": "Evidence of CNS tumors at screening assessment",
      "normalizedText": "Evidence of CNS tumors at screening assessment",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          3654328,
          4082164,
          4086181,
          4318660,
          4134439
        ],
        "conceptNames": [
          "Normal central nervous system",
          "Cyst of central nervous system",
          "Central nervous system finding",
          "Central nervous system deficit",
          "Injury of central nervous system"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (3654328, 4082164, 4086181, 4318660, 4134439)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "830121005",
            "display": "Normal central nervous system"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "277333006",
            "display": "Cyst of central nervous system"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "246556002",
            "display": "Central nervous system finding"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "220363002",
            "display": "Central nervous system deficit"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "128126004",
            "display": "Injury of central nervous system"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|830121005,http://snomed.info/sct|277333006,http://snomed.info/sct|246556002,http://snomed.info/sct|220363002,http://snomed.info/sct|128126004",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_8_2a",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 25
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "lesion (primary or metastatic) for analysis if available.\n8. Subject must have no history of brain metastases or evidence of CNS tumors at \nscreening assessment. Subjects with signs or symptoms of CNS involvement will \nundergo MRI (or CT scan if MRI is contraindicated) to confirm absence of CNS \nmetastases.\n9. Subject must have an Eastern Cooperative Oncology Group (ECOG) Performance \nScore of 0 – 1.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 0.9,
        "reasoning": "A finding of 'Normal central nervous system' is a clinical assessment, often from an imaging report, and is not typically stored as a queryable structured code. This requires confirmation at screening.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0026",
      "originalCriterionId": "INC_9",
      "criterionType": "inclusion",
      "atomicText": "Eastern Cooperative Oncology Group (ECOG) Performance Score of 0-1",
      "normalizedText": "Eastern Cooperative Oncology Group (ECOG) Performance Score of 0-1",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          36305384
        ],
        "conceptNames": [
          "ECOG Performance Status score"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36305384 AND 0-1",
        "sqlExecutable": true,
        "valueConstraint": "0-1"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "89247-1",
            "display": "ECOG Performance Status score"
          }
        ],
        "searchParams": "code=http://loinc.org|89247-1",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_9_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 26
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "undergo MRI (or CT scan if MRI is contraindicated) to confirm absence of CNS \nmetastases.\n9. Subject must have an Eastern Cooperative Oncology Group (ECOG) Performance \nScore of 0 – 1.\n10. Subjects with fluid retention, including ascites or pleural effusion, may be allowed \nat the discretion of the Investigator.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "ECOG Performance Status is a point-in-time clinical assessment score. While it may be stored in EHR flowsheets, it must be current for trial eligibility and is therefore confirmed at screening.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0027",
      "originalCriterionId": "INC_10",
      "criterionType": "inclusion",
      "atomicText": "Fluid retention",
      "normalizedText": "Fluid retention",
      "category": "disease_indication",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          433595,
          44832710,
          35207099,
          44835763,
          4155910
        ],
        "conceptNames": [
          "Edema",
          "Edema",
          "Fluid overload",
          "Fluid overload",
          "Generalized edema"
        ],
        "vocabularyIds": [
          "SNOMED",
          "ICD9CM",
          "ICD10CM"
        ],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (433595, 44832710, 35207099, 44835763, 4155910)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "267038008",
            "display": "Edema"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-9-cm",
            "code": "782.3",
            "display": "Edema"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E87.7",
            "display": "Fluid overload"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "21639008",
            "display": "Hypervolemia"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-9-cm",
            "code": "276.6",
            "display": "Fluid overload"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "271808008",
            "display": "Generalized edema"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|267038008,http://hl7.org/fhir/sid/icd-9-cm|782.3,http://hl7.org/fhir/sid/icd-10-cm|E87.7,http://snomed.info/sct|21639008,http://hl7.org/fhir/sid/icd-9-cm|276.6,http://snomed.info/sct|271808008",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_10_1",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 27
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "9. Subject must have an Eastern Cooperative Oncology Group (ECOG) Performance \nScore of 0 – 1.\n10. Subjects with fluid retention, including ascites or pleural effusion, may be allowed \nat the discretion of the Investigator.\n11. Subject must have adequate bone marrow, renal and hepatic function as follows:",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Edema is a standard diagnosis/finding with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0028",
      "originalCriterionId": "INC_10",
      "criterionType": "inclusion",
      "atomicText": "Ascites",
      "normalizedText": "Ascites",
      "category": "disease_indication",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          200528
        ],
        "conceptNames": [
          "Ascites"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (200528)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "389026000",
            "display": "Ascites"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R18.8",
            "display": "Other ascites"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|389026000,R18.8",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_10_2",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 28
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "9. Subject must have an Eastern Cooperative Oncology Group (ECOG) Performance \nScore of 0 – 1.\n10. Subjects with fluid retention, including ascites or pleural effusion, may be allowed \nat the discretion of the Investigator.\n11. Subject must have adequate bone marrow, renal and hepatic function as follows:",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Ascites is a standard diagnosis/finding with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0029",
      "originalCriterionId": "INC_10",
      "criterionType": "inclusion",
      "atomicText": "Pleural effusion",
      "normalizedText": "Pleural effusion",
      "category": "disease_indication",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          254061
        ],
        "conceptNames": [
          "Pleural effusion"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (254061)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "60046008",
            "display": "Pleural effusion"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "J91.8",
            "display": "Pleural effusion in other conditions"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|60046008,J91.8",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_10_3",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 29
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "9. Subject must have an Eastern Cooperative Oncology Group (ECOG) Performance \nScore of 0 – 1.\n10. Subjects with fluid retention, including ascites or pleural effusion, may be allowed \nat the discretion of the Investigator.\n11. Subject must have adequate bone marrow, renal and hepatic function as follows:",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Pleural effusion is a standard diagnosis/finding with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0030",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Absolute neutrophil count (ANC) >= 1,500/mm3",
      "normalizedText": "Absolute neutrophil count (ANC) >= 1,500/mm3",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3017732
        ],
        "conceptNames": [
          "Neutrophils [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 1500",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 1500"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26499-4",
            "display": "Neutrophils [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26499-4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 30
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Neutrophil count is a standard lab value with a mapped LOINC code, directly queryable from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0031",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Platelets >= 100,000/mm3",
      "normalizedText": "Platelets >= 100,000/mm3",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number >= 100000",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 100000"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_1b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 31
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Platelet count is a standard lab value with a mapped LOINC code, directly queryable from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0032",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Hemoglobin >= 9.0 g/dL",
      "normalizedText": "Hemoglobin >= 9.0 g/dL",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3000963
        ],
        "conceptNames": [
          "Hemoglobin [Mass/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3000963 AND value_as_number >= 9.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 9.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|718-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_1c",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 32
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Hemoglobin is a standard lab value with a mapped LOINC code, directly queryable from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0033",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Serum calculated creatinine clearance > 50 mL/min by Cockcroft-Gault",
      "normalizedText": "Serum calculated creatinine clearance > 50 mL/min by Cockcroft-Gault",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3016723
        ],
        "conceptNames": [
          "Creatinine [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number > 50",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number > 50"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|2160-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 33
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Serum creatinine is a standard lab value with a mapped LOINC code, directly queryable from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0034",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Liver metastases are present",
      "normalizedText": "Liver metastases are present",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          36770544
        ],
        "conceptNames": [
          "Metastasis to liver"
        ],
        "vocabularyIds": [
          "Cancer Modifier"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36770544",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C78.7",
            "display": "Secondary malignant neoplasm of liver and intrahepatic bile duct"
          }
        ],
        "searchParams": "code=http://hl7.org/fhir/sid/icd-10-cm|C78.7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_3a1a1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 34
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "Metastasis to liver is a diagnosis with a standard code. It can be queried from the condition domain to identify a history of liver metastases.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0035",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "AST <= 2.5 x ULN",
      "normalizedText": "AST <= 2.5 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3013721
        ],
        "conceptNames": [
          "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number <= 2.5",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 2.5"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1920-8",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_3a1b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 35
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Aspartate aminotransferase (AST) is a standard lab value with a mapped LOINC code, directly queryable from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0036",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "ALT <= 2.5 x ULN",
      "normalizedText": "ALT <= 2.5 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3006923
        ],
        "conceptNames": [
          "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number <= 2.5",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 2.5"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1742-6",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_3a1c",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 36
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Alanine aminotransferase (ALT) is a standard lab value with a mapped LOINC code, directly queryable from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0037",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Liver metastases are present",
      "normalizedText": "Liver metastases are present",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          36770544
        ],
        "conceptNames": [
          "Metastasis to liver"
        ],
        "vocabularyIds": [
          "Cancer Modifier"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36770544",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C78.7",
            "display": "Secondary malignant neoplasm of liver and intrahepatic bile duct"
          }
        ],
        "searchParams": "code=http://hl7.org/fhir/sid/icd-10-cm|C78.7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_3a2a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 37
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "Metastasis to liver is a diagnosis with a standard code. It can be queried from the condition domain to identify a history of liver metastases.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0038",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "AST < 5.0 x ULN",
      "normalizedText": "AST < 5.0 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3013721
        ],
        "conceptNames": [
          "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number < 5.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number < 5.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1920-8",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_3a2b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 38
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Aspartate aminotransferase (AST) is a standard lab value with a mapped LOINC code, directly queryable from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0039",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "ALT < 5.0 x ULN",
      "normalizedText": "ALT < 5.0 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3006923
        ],
        "conceptNames": [
          "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number < 5.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number < 5.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1742-6",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_3a2c",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 39
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Alanine aminotransferase (ALT) is a standard lab value with a mapped LOINC code, directly queryable from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0040",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Gilbert's Syndrome is present",
      "normalizedText": "Gilbert's Syndrome is present",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4099740
        ],
        "conceptNames": [
          "Gilbert's syndrome"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "27503000",
            "display": "Gilbert's syndrome"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E80.4",
            "display": "Gilbert syndrome"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|27503000,E80.4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_3b1a1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 40
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Gilbert's syndrome is a standard diagnosis with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0041",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Bilirubin <= 1.5 x ULN",
      "normalizedText": "Bilirubin <= 1.5 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3024128
        ],
        "conceptNames": [
          "Bilirubin.total [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number <= 1.5",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 1.5"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1975-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_3b1b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 41
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Total bilirubin is a standard lab value with a mapped LOINC code, directly queryable from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0042",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Gilbert's Syndrome is present",
      "normalizedText": "Gilbert's Syndrome is present",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4099740
        ],
        "conceptNames": [
          "Gilbert's syndrome"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "27503000",
            "display": "Gilbert's syndrome"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E80.4",
            "display": "Gilbert syndrome"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|27503000,E80.4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_3b2a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 42
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Gilbert's syndrome is a standard diagnosis with a valid OMOP concept, queryable from the condition domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0043",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Bilirubin >= 1.5 x ULN",
      "normalizedText": "Bilirubin >= 1.5 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3024128
        ],
        "conceptNames": [
          "Bilirubin.total [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number >= 1.5",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 1.5"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1975-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_3b2b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 43
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "11. Subject must have adequate bone marrow, renal and hepatic function as follows:\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); \nPlatelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL; \n● Renal function: Serum calculated creatinine clearance > 50 mL/min according \nto the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may \nbe done by a local direct measurement method (e.g., 24 hour urine collection \nor radioisotope) at the investigator's di...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Total bilirubin is a standard lab value with a mapped LOINC code, directly queryable from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0044",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "Gender is female",
      "normalizedText": "Gender is female",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [
          4015271,
          4009882,
          4010345,
          4010845,
          4014457
        ],
        "conceptNames": [
          "Baby female",
          "Well female child",
          "Well female adult",
          "Well female elder",
          "Two female babies"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM person WHERE person_concept_id IN (4015271, 4009882, 4010345, 4010845, 4014457)",
        "sqlExecutable": false
      },
      "fhirQuery": {
        "resourceType": "Patient",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "169839008",
            "display": "Baby female"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "102508009",
            "display": "Well female child"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "102514002",
            "display": "Well female adult"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "102517009",
            "display": "Well female elder"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "169841009",
            "display": "Two female babies"
          }
        ],
        "searchParams": "identifier=http://snomed.info/sct|169839008,http://snomed.info/sct|102508009,http://snomed.info/sct|102514002,http://snomed.info/sct|102517009,http://snomed.info/sct|169841009",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_12_1a1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 44
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "Gilbert's Syndrome is present, then bilirubin ≥ 1.5 × ULN.\n12. Female subjects of childbearing potential (i.e., those who are not postmenopausal \nfor at least 1 year or surgically sterile by bilateral tubal ligation, bilateral \noophorectomy or hysterectomy) and their male partners should practice at least one \nof the methods of birth control listed below during study and for at least 6 months \nafter treatment with paclitaxel chemotherapy. Male subjects and their female \npartners of childbeari...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "SQL template requires manual concept selection",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "This concept relates to sex (Female), which is a standard demographic field and directly queryable.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0045",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "Postmenopausal for at least 1 year",
      "normalizedText": "Postmenopausal for at least 1 year",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          4015271,
          4009882,
          4010345,
          4010845,
          4014457
        ],
        "conceptNames": [
          "Baby female",
          "Well female child",
          "Well female adult",
          "Well female elder",
          "Two female babies"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "169839008",
            "display": "Baby female"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "102508009",
            "display": "Well female child"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "102514002",
            "display": "Well female adult"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "102517009",
            "display": "Well female elder"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "169841009",
            "display": "Two female babies"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|169839008,http://snomed.info/sct|102508009,http://snomed.info/sct|102514002,http://snomed.info/sct|102517009,http://snomed.info/sct|169841009",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_12_1a1b1a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 45
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "Gilbert's Syndrome is present, then bilirubin ≥ 1.5 × ULN.\n12. Female subjects of childbearing potential (i.e., those who are not postmenopausal \nfor at least 1 year or surgically sterile by bilateral tubal ligation, bilateral \noophorectomy or hysterectomy) and their male partners should practice at least one \nof the methods of birth control listed below during study and for at least 6 months \nafter treatment with paclitaxel chemotherapy. Male subjects and their female \npartners of childbeari...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "This concept relates to sex (Female), which is a standard demographic field and directly queryable.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0046",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "Surgically sterile by bilateral tubal ligation",
      "normalizedText": "Surgically sterile by bilateral tubal ligation",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          42536952,
          42536960,
          42536954,
          42537021,
          4117038
        ],
        "conceptNames": [
          "Elective upper segment cesarean section with bilateral tubal ligation",
          "Elective lower segment cesarean section with bilateral tubal ligation",
          "Emergency upper segment cesarean section with bilateral tubal ligation",
          "Emergency lower segment cesarean section with bilateral tubal ligation",
          "Ligation of bilateral fallopian tubes"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (42536952, 42536960, 42536954, 42537021, 4117038)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "736018001",
            "display": "Elective upper segment cesarean section with bilateral tubal ligation"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "736026009",
            "display": "Elective lower segment cesarean section with bilateral tubal ligation"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "736020003",
            "display": "Emergency upper segment cesarean section with bilateral tubal ligation"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "736118004",
            "display": "Emergency lower segment cesarean section with bilateral tubal ligation"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "287664005",
            "display": "Ligation of bilateral fallopian tubes"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|736018001,http://snomed.info/sct|736026009,http://snomed.info/sct|736020003,http://snomed.info/sct|736118004,http://snomed.info/sct|287664005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_12_1a1b1b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 46
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "Gilbert's Syndrome is present, then bilirubin ≥ 1.5 × ULN.\n12. Female subjects of childbearing potential (i.e., those who are not postmenopausal \nfor at least 1 year or surgically sterile by bilateral tubal ligation, bilateral \noophorectomy or hysterectomy) and their male partners should practice at least one \nof the methods of birth control listed below during study and for at least 6 months \nafter treatment with paclitaxel chemotherapy. Male subjects and their female \npartners of childbeari...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "This is a specific surgical procedure with a valid OMOP concept, queryable from the procedure domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0047",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "Surgically sterile by bilateral oophorectomy",
      "normalizedText": "Surgically sterile by bilateral oophorectomy",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          43531553,
          4297990,
          43021519
        ],
        "conceptNames": [
          "Laparoscopic bilateral oophorectomy",
          "Excision of bilateral ovaries",
          "Excision of bilateral ovaries for malignant neoplasm of ovary"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (43531553, 4297990, 43021519)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "609275002",
            "display": "Laparoscopic bilateral oophorectomy"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "76876009",
            "display": "Excision of bilateral ovaries"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "473239006",
            "display": "Excision of bilateral ovaries for malignant neoplasm of ovary"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|609275002,http://snomed.info/sct|76876009,http://snomed.info/sct|473239006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_12_1a1b1c",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 47
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "Gilbert's Syndrome is present, then bilirubin ≥ 1.5 × ULN.\n12. Female subjects of childbearing potential (i.e., those who are not postmenopausal \nfor at least 1 year or surgically sterile by bilateral tubal ligation, bilateral \noophorectomy or hysterectomy) and their male partners should practice at least one \nof the methods of birth control listed below during study and for at least 6 months \nafter treatment with paclitaxel chemotherapy. Male subjects and their female \npartners of childbeari...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Oophorectomy is a standard surgical procedure with a valid OMOP concept, queryable from the procedure domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0048",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "Surgically sterile by hysterectomy",
      "normalizedText": "Surgically sterile by hysterectomy",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          4127886,
          4023403,
          4021530
        ],
        "conceptNames": [
          "Hysterectomy",
          "Total hysterectomy",
          "Radical hysterectomy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (4127886, 4023403, 4021530)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "236886002",
            "display": "Hysterectomy"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "116140006",
            "display": "Total hysterectomy"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "116142003",
            "display": "Radical hysterectomy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|236886002,http://snomed.info/sct|116140006,http://snomed.info/sct|116142003",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_12_1a1b1d",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 48
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "Gilbert's Syndrome is present, then bilirubin ≥ 1.5 × ULN.\n12. Female subjects of childbearing potential (i.e., those who are not postmenopausal \nfor at least 1 year or surgically sterile by bilateral tubal ligation, bilateral \noophorectomy or hysterectomy) and their male partners should practice at least one \nof the methods of birth control listed below during study and for at least 6 months \nafter treatment with paclitaxel chemotherapy. Male subjects and their female \npartners of childbeari...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Hysterectomy is a standard surgical procedure with a valid OMOP concept, queryable from the procedure domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0049",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "Gender is male",
      "normalizedText": "Gender is male",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [
          4135840,
          4015423,
          4198781,
          4015271,
          4140373
        ],
        "conceptNames": [
          "Maleo",
          "Baby male",
          "Thermales",
          "Baby female",
          "Feminized male"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM person WHERE person_concept_id IN (4135840, 4015423, 4198781, 4015271, 4140373)",
        "sqlExecutable": false
      },
      "fhirQuery": {
        "resourceType": "Patient",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "31792003",
            "display": "Maleo"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "169838000",
            "display": "Baby male"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "433198003",
            "display": "Thermales"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "169839008",
            "display": "Baby female"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "32951002",
            "display": "Feminized male"
          }
        ],
        "searchParams": "identifier=http://snomed.info/sct|31792003,http://snomed.info/sct|169838000,http://snomed.info/sct|433198003,http://snomed.info/sct|169839008,http://snomed.info/sct|32951002",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_12_2a1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 49
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "Gilbert's Syndrome is present, then bilirubin ≥ 1.5 × ULN.\n12. Female subjects of childbearing potential (i.e., those who are not postmenopausal \nfor at least 1 year or surgically sterile by bilateral tubal ligation, bilateral \noophorectomy or hysterectomy) and their male partners should practice at least one \nof the methods of birth control listed below during study and for at least 6 months \nafter treatment with paclitaxel chemotherapy. Male subjects and their female \npartners of childbeari...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "SQL template requires manual concept selection",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "This concept maps to sex (Male), which is a standard demographic field and directly queryable.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0050",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "Vasectomy documented",
      "normalizedText": "Vasectomy documented",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          4330583,
          4163273,
          4170966,
          4072179
        ],
        "conceptNames": [
          "Vasectomy",
          "Male sterilization",
          "Ligation vasectomy",
          "Reversal of vasectomy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (4330583, 4163273, 4170966, 4072179)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22523008",
            "display": "Vasectomy"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "399141000",
            "display": "Male sterilization"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "276486001",
            "display": "Ligation vasectomy"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "176490000",
            "display": "Reversal of vasectomy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22523008,http://snomed.info/sct|399141000,http://snomed.info/sct|276486001,http://snomed.info/sct|176490000",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_12_2a1b1a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 50
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "Gilbert's Syndrome is present, then bilirubin ≥ 1.5 × ULN.\n12. Female subjects of childbearing potential (i.e., those who are not postmenopausal \nfor at least 1 year or surgically sterile by bilateral tubal ligation, bilateral \noophorectomy or hysterectomy) and their male partners should practice at least one \nof the methods of birth control listed below during study and for at least 6 months \nafter treatment with paclitaxel chemotherapy. Male subjects and their female \npartners of childbeari...",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 1.0,
        "reasoning": "Vasectomy is a standard surgical procedure with a valid OMOP concept, queryable from the procedure domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0051",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "Partner not of childbearing potential",
      "normalizedText": "Partner not of childbearing potential",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_12_2a1b1b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 51
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "Gilbert's Syndrome is present, then bilirubin ≥ 1.5 × ULN.\n12. Female subjects of childbearing potential (i.e., those who are not postmenopausal \nfor at least 1 year or surgically sterile by bilateral tubal ligation, bilateral \noophorectomy or hysterectomy) and their male partners should practice at least one \nof the methods of birth control listed below during study and for at least 6 months \nafter treatment with paclitaxel chemotherapy. Male subjects and their female \npartners of childbeari...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "SQL template requires manual concept selection",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 0.95,
        "reasoning": "Pregnancy status requires a real-time assessment (e.g., a current pregnancy test) at the time of screening. Historical pregnancy diagnoses are not sufficient to determine current status.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0052",
      "originalCriterionId": "INC_13",
      "criterionType": "inclusion",
      "atomicText": "Subject is capable of understanding parameters as outlined in the protocol",
      "normalizedText": "Subject is capable of understanding parameters as outlined in the protocol",
      "category": "other",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_13_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 52
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "used, the subject and her partner should also use a single-barrier method.\n13. Subject must be capable of understanding and complying with parameters as \noutlined in the protocol and able to sign and date the informed consent approved by \nan Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.\nRationale for Inclusion Criteria",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped to a standard OMOP concept (omopConceptId is null). Unmapped criteria cannot be queried and default to manual screening.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0053",
      "originalCriterionId": "INC_13",
      "criterionType": "inclusion",
      "atomicText": "Subject is capable of complying with parameters as outlined in the protocol",
      "normalizedText": "Subject is capable of complying with parameters as outlined in the protocol",
      "category": "other",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_13_2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 53
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "used, the subject and her partner should also use a single-barrier method.\n13. Subject must be capable of understanding and complying with parameters as \noutlined in the protocol and able to sign and date the informed consent approved by \nan Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.\nRationale for Inclusion Criteria",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped to a standard OMOP concept (omopConceptId is null). Unmapped criteria cannot be queried and default to manual screening.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0054",
      "originalCriterionId": "INC_13",
      "criterionType": "inclusion",
      "atomicText": "Subject signed and dated the informed consent form approved by an IEC/IRB",
      "normalizedText": "Subject signed and dated the informed consent form approved by an IEC/IRB",
      "category": "other",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          3018196
        ],
        "conceptNames": [
          "Informed consent obtained"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (3018196)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "19826-7",
            "display": "Informed consent obtained"
          }
        ],
        "searchParams": "code=http://loinc.org|19826-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_13_3a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 54
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "used, the subject and her partner should also use a single-barrier method.\n13. Subject must be capable of understanding and complying with parameters as \noutlined in the protocol and able to sign and date the informed consent approved by \nan Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.\nRationale for Inclusion Criteria",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "NOT_APPLICABLE",
        "confidence": 1.0,
        "reasoning": "Informed consent is a procedural/administrative requirement for study participation, not a clinical characteristic of the patient. It is not queryable from historical data.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0055",
      "originalCriterionId": "EXC_1",
      "criterionType": "exclusion",
      "atomicText": "Known hypersensitivity to paclitaxel",
      "normalizedText": "Known hypersensitivity to paclitaxel",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          4273629
        ],
        "conceptNames": [
          "Chemotherapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4273629)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "367336001",
            "display": "Chemotherapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|367336001",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_1_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 55
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "(13) This is standard criteria in accordance with harmonized Good Clinical Practice.\n5.2.2 Exclusion Criteria\n1. Subject has a known hypersensitivity to paclitaxel or to other drugs formulated \nwith polyethoxylated castor oil (Cremophor).\n2. Subject has a known hypersensitivity to platinum compounds.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Chemotherapy is a standard treatment procedure with a mapped OMOP concept. It can be identified from historical EHR/claims data in the procedure or drug exposure domains.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0056",
      "originalCriterionId": "EXC_1",
      "criterionType": "exclusion",
      "atomicText": "Known hypersensitivity to drugs formulated with polyethoxylated castor oil (Cremophor)",
      "normalizedText": "Known hypersensitivity to drugs formulated with polyethoxylated castor oil (Cremophor)",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_1_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 56
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "(13) This is standard criteria in accordance with harmonized Good Clinical Practice.\n5.2.2 Exclusion Criteria\n1. Subject has a known hypersensitivity to paclitaxel or to other drugs formulated \nwith polyethoxylated castor oil (Cremophor).\n2. Subject has a known hypersensitivity to platinum compounds.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped to a standard OMOP concept (omopConceptId is null). Unmapped criteria cannot be queried and default to manual screening.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0057",
      "originalCriterionId": "EXC_2",
      "criterionType": "exclusion",
      "atomicText": "Known hypersensitivity to platinum compounds",
      "normalizedText": "Known hypersensitivity to platinum compounds",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_2_1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 57
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "1. Subject has a known hypersensitivity to paclitaxel or to other drugs formulated \nwith polyethoxylated castor oil (Cremophor).\n2. Subject has a known hypersensitivity to platinum compounds.\n3. Subjects with peripheral neuropathy ≥ grade 2.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped to a standard OMOP concept (omopConceptId is null). Unmapped criteria cannot be queried and default to manual screening.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0058",
      "originalCriterionId": "EXC_3",
      "criterionType": "exclusion",
      "atomicText": "Peripheral neuropathy with grade >= 2",
      "normalizedText": "Peripheral neuropathy with grade >= 2",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4117779
        ],
        "conceptNames": [
          "Peripheral nerve disease"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4117779)",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 2"
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "302226006",
            "display": "Peripheral nerve disease"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G62.9",
            "display": "Polyneuropathy, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|302226006,G62.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_3_1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 58
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "2. Subject has a known hypersensitivity to platinum compounds.\n3. Subjects with peripheral neuropathy ≥ grade 2.\n4. Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon \n19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. \nSubjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Peripheral nerve disease is a standard diagnosis with a mapped OMOP concept. It can be queried from the condition occurrence domain in EHR/claims data.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0059",
      "originalCriterionId": "EXC_4",
      "criterionType": "exclusion",
      "atomicText": "Squamous non-small cell lung cancer",
      "normalizedText": "Squamous non-small cell lung cancer",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4115276
        ],
        "conceptNames": [
          "Non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of bronchus or lung"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254637007,C34.90",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_4_1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 59
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "3. Subjects with peripheral neuropathy ≥ grade 2.\n4. Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon \n19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. \nSubjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry.\n5. A history of seizure within 12 months prior to study entry.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Non-small cell lung cancer is a standard diagnosis with a mapped OMOP concept. It can be queried from the condition occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0060",
      "originalCriterionId": "EXC_4",
      "criterionType": "exclusion",
      "atomicText": "EGFR exon 19 deletion mutation",
      "normalizedText": "EGFR exon 19 deletion mutation",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3014444
        ],
        "conceptNames": [
          "EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "50917-9",
            "display": "EGFR gene mutation analysis"
          }
        ],
        "searchParams": "code=http://loinc.org|50917-9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_4_1b1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 60
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "3. Subjects with peripheral neuropathy ≥ grade 2.\n4. Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon \n19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. \nSubjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry.\n5. A history of seizure within 12 months prior to study entry.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.9,
        "reasoning": "EGFR mutation status is a structured lab result (genomic marker) with a mapped OMOP concept. It is increasingly available in structured format in EHRs and can be queried from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0061",
      "originalCriterionId": "EXC_4",
      "criterionType": "exclusion",
      "atomicText": "EGFR L858R mutation in exon 21",
      "normalizedText": "EGFR L858R mutation in exon 21",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3014444
        ],
        "conceptNames": [
          "EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "50917-9",
            "display": "EGFR gene mutation analysis"
          }
        ],
        "searchParams": "code=http://loinc.org|50917-9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_4_1b1b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 61
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "3. Subjects with peripheral neuropathy ≥ grade 2.\n4. Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon \n19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. \nSubjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry.\n5. A history of seizure within 12 months prior to study entry.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.9,
        "reasoning": "EGFR mutation status is a structured lab result (genomic marker) with a mapped OMOP concept. It is increasingly available in structured format in EHRs and can be queried from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0062",
      "originalCriterionId": "EXC_4",
      "criterionType": "exclusion",
      "atomicText": "Received prior therapy targeting EGFR mutation",
      "normalizedText": "Received prior therapy targeting EGFR mutation",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.5,
        "impactScore": 0.995,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3014444
        ],
        "conceptNames": [
          "EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "50917-9",
            "display": "EGFR gene mutation analysis"
          }
        ],
        "searchParams": "code=http://loinc.org|50917-9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_4_1b2a",
        "groupLogic": "NOT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 62
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "3. Subjects with peripheral neuropathy ≥ grade 2.\n4. Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon \n19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. \nSubjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry.\n5. A history of seizure within 12 months prior to study entry.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.9,
        "reasoning": "EGFR mutation status is a structured lab result (genomic marker) with a mapped OMOP concept. It is increasingly available in structured format in EHRs and can be queried from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0063",
      "originalCriterionId": "EXC_4",
      "criterionType": "exclusion",
      "atomicText": "ALK gene rearrangement",
      "normalizedText": "ALK gene rearrangement",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          21492143
        ],
        "conceptNames": [
          "ALK gene rearrangements [Presence] in Blood or Tissue by FISH"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (21492143)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "62385-0",
            "display": "ALK gene rearrangement analysis"
          }
        ],
        "searchParams": "code=http://loinc.org|62385-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_4_1c",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 63
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "3. Subjects with peripheral neuropathy ≥ grade 2.\n4. Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon \n19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. \nSubjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry.\n5. A history of seizure within 12 months prior to study entry.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.9,
        "reasoning": "ALK rearrangement status is a structured lab result (genomic marker) with a mapped OMOP concept. It is queryable from the measurement or observation domains in EHRs with genomic data.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0064",
      "originalCriterionId": "EXC_4",
      "criterionType": "exclusion",
      "atomicText": "EGFR mutation status is known",
      "normalizedText": "EGFR mutation status is known",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3014444
        ],
        "conceptNames": [
          "EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3014444)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "50917-9",
            "display": "EGFR gene mutation analysis"
          }
        ],
        "searchParams": "code=http://loinc.org|50917-9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_4_2a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 64
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "3. Subjects with peripheral neuropathy ≥ grade 2.\n4. Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon \n19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. \nSubjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry.\n5. A history of seizure within 12 months prior to study entry.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.9,
        "reasoning": "EGFR mutation status is a structured lab result (genomic marker) with a mapped OMOP concept. It is increasingly available in structured format in EHRs and can be queried from the measurement domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0065",
      "originalCriterionId": "EXC_4",
      "criterionType": "exclusion",
      "atomicText": "ALK gene rearrangement status is known",
      "normalizedText": "ALK gene rearrangement status is known",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          21492143
        ],
        "conceptNames": [
          "ALK gene rearrangements [Presence] in Blood or Tissue by FISH"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (21492143)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "62385-0",
            "display": "ALK gene rearrangement analysis"
          }
        ],
        "searchParams": "code=http://loinc.org|62385-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_4_2b",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 65
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "3. Subjects with peripheral neuropathy ≥ grade 2.\n4. Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon \n19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. \nSubjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry.\n5. A history of seizure within 12 months prior to study entry.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.9,
        "reasoning": "ALK rearrangement status is a structured lab result (genomic marker) with a mapped OMOP concept. It is queryable from the measurement or observation domains in EHRs with genomic data.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0066",
      "originalCriterionId": "EXC_5",
      "criterionType": "exclusion",
      "atomicText": "History of seizure",
      "normalizedText": "History of seizure",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 2.0,
        "impactScore": 0.02,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          377091
        ],
        "conceptNames": [
          "Seizure"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (377091)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "91175000",
            "display": "Seizure"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G40.909",
            "display": "Epilepsy, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|91175000,G40.909",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 66
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "Subjects' EGFR mutation and ALK gene rearrangement status must be known prior \nto study entry.\n5. A history of seizure within 12 months prior to study entry.\n6. Subject has received prior cytotoxic chemotherapy or chemoradiotherapy for \nNSCLC, except adjuvant or neoadjuvant therapy > 12 months prior to C1D-2, or \nsubject has received targeted small molecule monotherapy for EGFR and/or \nALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Seizure is a standard diagnosis/symptom with a mapped OMOP concept. It can be queried from the condition occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0067",
      "originalCriterionId": "EXC_6",
      "criterionType": "exclusion",
      "atomicText": "Subject has received prior cytotoxic chemotherapy for NSCLC",
      "normalizedText": "Subject has received prior cytotoxic chemotherapy for NSCLC",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4115276
        ],
        "conceptNames": [
          "Non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of bronchus or lung"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254637007,C34.90",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_6_1a1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 67
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "5. A history of seizure within 12 months prior to study entry.\n6. Subject has received prior cytotoxic chemotherapy or chemoradiotherapy for \nNSCLC, except adjuvant or neoadjuvant therapy > 12 months prior to C1D-2, or \nsubject has received targeted small molecule monotherapy for EGFR and/or \nALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Non-small cell lung cancer is a standard diagnosis with a mapped OMOP concept. It can be queried from the condition occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0068",
      "originalCriterionId": "EXC_6",
      "criterionType": "exclusion",
      "atomicText": "Subject has received prior chemoradiotherapy for NSCLC",
      "normalizedText": "Subject has received prior chemoradiotherapy for NSCLC",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4115276
        ],
        "conceptNames": [
          "Non-small cell lung cancer"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id = 4115276",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254637007",
            "display": "Non-small cell lung cancer"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C34.90",
            "display": "Malignant neoplasm of unspecified part of bronchus or lung"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254637007,C34.90",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_6_1a2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 68
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "5. A history of seizure within 12 months prior to study entry.\n6. Subject has received prior cytotoxic chemotherapy or chemoradiotherapy for \nNSCLC, except adjuvant or neoadjuvant therapy > 12 months prior to C1D-2, or \nsubject has received targeted small molecule monotherapy for EGFR and/or \nALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Non-small cell lung cancer is a standard diagnosis with a mapped OMOP concept. It can be queried from the condition occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0069",
      "originalCriterionId": "EXC_6",
      "criterionType": "exclusion",
      "atomicText": "Subject has received adjuvant therapy",
      "normalizedText": "Subject has received adjuvant therapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [
          44808409
        ],
        "conceptNames": [
          "Neoadjuvant chemotherapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM drug_exposure WHERE drug_concept_id IN (44808409)",
        "sqlExecutable": false
      },
      "fhirQuery": {
        "resourceType": "MedicationRequest",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "829591000000101",
            "display": "Neoadjuvant chemotherapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|829591000000101",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_6_1b1a1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 69
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "5. A history of seizure within 12 months prior to study entry.\n6. Subject has received prior cytotoxic chemotherapy or chemoradiotherapy for \nNSCLC, except adjuvant or neoadjuvant therapy > 12 months prior to C1D-2, or \nsubject has received targeted small molecule monotherapy for EGFR and/or \nALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "SQL template requires manual concept selection",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "Neoadjuvant chemotherapy is a specific treatment regimen with a mapped OMOP concept. It can be identified from procedure, drug, or observation domains.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0070",
      "originalCriterionId": "EXC_6",
      "criterionType": "exclusion",
      "atomicText": "Subject has received neoadjuvant therapy",
      "normalizedText": "Subject has received neoadjuvant therapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [
          44808409
        ],
        "conceptNames": [
          "Neoadjuvant chemotherapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (44808409)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationRequest",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "829591000000101",
            "display": "Neoadjuvant chemotherapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|829591000000101",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_6_1b1a2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 70
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "5. A history of seizure within 12 months prior to study entry.\n6. Subject has received prior cytotoxic chemotherapy or chemoradiotherapy for \nNSCLC, except adjuvant or neoadjuvant therapy > 12 months prior to C1D-2, or \nsubject has received targeted small molecule monotherapy for EGFR and/or \nALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "Neoadjuvant chemotherapy is a specific treatment regimen with a mapped OMOP concept. It can be identified from procedure, drug, or observation domains.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0071",
      "originalCriterionId": "EXC_6",
      "criterionType": "exclusion",
      "atomicText": "Subject has received adjuvant therapy",
      "normalizedText": "Subject has received adjuvant therapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [
          44808409
        ],
        "conceptNames": [
          "Neoadjuvant chemotherapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM drug_exposure WHERE drug_concept_id IN (44808409)",
        "sqlExecutable": false
      },
      "fhirQuery": {
        "resourceType": "MedicationRequest",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "829591000000101",
            "display": "Neoadjuvant chemotherapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|829591000000101",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_6_1b2a1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 71
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "5. A history of seizure within 12 months prior to study entry.\n6. Subject has received prior cytotoxic chemotherapy or chemoradiotherapy for \nNSCLC, except adjuvant or neoadjuvant therapy > 12 months prior to C1D-2, or \nsubject has received targeted small molecule monotherapy for EGFR and/or \nALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "SQL template requires manual concept selection",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "Neoadjuvant chemotherapy is a specific treatment regimen with a mapped OMOP concept. It can be identified from procedure, drug, or observation domains.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0072",
      "originalCriterionId": "EXC_6",
      "criterionType": "exclusion",
      "atomicText": "Subject has received neoadjuvant therapy",
      "normalizedText": "Subject has received neoadjuvant therapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [
          44808409
        ],
        "conceptNames": [
          "Neoadjuvant chemotherapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (44808409)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationRequest",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "829591000000101",
            "display": "Neoadjuvant chemotherapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|829591000000101",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_6_1b2a1b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 72
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "5. A history of seizure within 12 months prior to study entry.\n6. Subject has received prior cytotoxic chemotherapy or chemoradiotherapy for \nNSCLC, except adjuvant or neoadjuvant therapy > 12 months prior to C1D-2, or \nsubject has received targeted small molecule monotherapy for EGFR and/or \nALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "Neoadjuvant chemotherapy is a specific treatment regimen with a mapped OMOP concept. It can be identified from procedure, drug, or observation domains.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0073",
      "originalCriterionId": "EXC_7",
      "criterionType": "exclusion",
      "atomicText": "Received anti-cancer Chinese medicine",
      "normalizedText": "Received anti-cancer Chinese medicine",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_7_1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 73
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "ALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2.\n7. Subject has received anti-cancer Chinese medicine or anti-cancer herbal remedies \nwithin 14 days prior to C1D-2.\n8. Subject has undergone focal External Beam Radiation Therapy (EBRT) to bone \n≤ 2 weeks prior to C1D-2; or subject has undergone EBRT to larger fields \n(i.e., 100 cm2 to thorax) ≤ 4 weeks prior to C1D-2.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped to a standard OMOP concept (omopConceptId is null). Unmapped criteria cannot be queried and default to manual screening.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0074",
      "originalCriterionId": "EXC_7",
      "criterionType": "exclusion",
      "atomicText": "Received anti-cancer herbal remedies",
      "normalizedText": "Received anti-cancer herbal remedies",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_7_1b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 74
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "ALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior \nto C1D-2.\n7. Subject has received anti-cancer Chinese medicine or anti-cancer herbal remedies \nwithin 14 days prior to C1D-2.\n8. Subject has undergone focal External Beam Radiation Therapy (EBRT) to bone \n≤ 2 weeks prior to C1D-2; or subject has undergone EBRT to larger fields \n(i.e., 100 cm2 to thorax) ≤ 4 weeks prior to C1D-2.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped to a standard OMOP concept (omopConceptId is null). Unmapped criteria cannot be queried and default to manual screening.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0075",
      "originalCriterionId": "EXC_8",
      "criterionType": "exclusion",
      "atomicText": "Undergone focal External Beam Radiation Therapy (EBRT) to bone",
      "normalizedText": "Undergone focal External Beam Radiation Therapy (EBRT) to bone",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          600054592
        ],
        "conceptNames": [
          "Radiation Therapy"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id = 600054592",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C15313",
            "display": "Radiation Therapy"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C15313",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_8_1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 75
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "7. Subject has received anti-cancer Chinese medicine or anti-cancer herbal remedies \nwithin 14 days prior to C1D-2.\n8. Subject has undergone focal External Beam Radiation Therapy (EBRT) to bone \n≤ 2 weeks prior to C1D-2; or subject has undergone EBRT to larger fields \n(i.e., 100 cm2 to thorax) ≤ 4 weeks prior to C1D-2.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Radiation therapy is a standard procedure with a mapped OMOP concept. It is queryable from the procedure occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0076",
      "originalCriterionId": "EXC_8",
      "criterionType": "exclusion",
      "atomicText": "Undergone External Beam Radiation Therapy (EBRT) to larger fields (i.e., 100 cm² to thorax)",
      "normalizedText": "Undergone External Beam Radiation Therapy (EBRT) to larger fields (i.e., 100 cm² to thorax)",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          600054592
        ],
        "conceptNames": [
          "Radiation Therapy"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id = 600054592",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 100"
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C15313",
            "display": "Radiation Therapy"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C15313",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_8_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 76
      },
      "provenance": {
        "pageNumber": 36,
        "textSnippet": "7. Subject has received anti-cancer Chinese medicine or anti-cancer herbal remedies \nwithin 14 days prior to C1D-2.\n8. Subject has undergone focal External Beam Radiation Therapy (EBRT) to bone \n≤ 2 weeks prior to C1D-2; or subject has undergone EBRT to larger fields \n(i.e., 100 cm2 to thorax) ≤ 4 weeks prior to C1D-2.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Radiation therapy is a standard procedure with a mapped OMOP concept. It is queryable from the procedure occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0077",
      "originalCriterionId": "EXC_9",
      "criterionType": "exclusion",
      "atomicText": "Medical condition that places the subject at an unacceptably high risk for toxicities in the opinion of the Investigator",
      "normalizedText": "Medical condition that places the subject at an unacceptably high risk for toxicities in the opinion of the Investigator",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_9_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 77
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "9. Any medical condition, which in the opinion of the Investigator, places the subject \nat an unacceptably high risk for toxicities, or any subject circumstance which \nprohibits trial participation according to local law.\n10. Subject is pregnant or lactating.\n11. Subject has previously been treated with a PARP inhibitor.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped to a standard OMOP concept (omopConceptId is null). Unmapped criteria cannot be queried and default to manual screening.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0078",
      "originalCriterionId": "EXC_9",
      "criterionType": "exclusion",
      "atomicText": "Subject circumstance which prohibits trial participation according to local law",
      "normalizedText": "Subject circumstance which prohibits trial participation according to local law",
      "category": "other",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_9_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 78
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "9. Any medical condition, which in the opinion of the Investigator, places the subject \nat an unacceptably high risk for toxicities, or any subject circumstance which \nprohibits trial participation according to local law.\n10. Subject is pregnant or lactating.\n11. Subject has previously been treated with a PARP inhibitor.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 1.0,
        "reasoning": "Criterion is unmapped to a standard OMOP concept (omopConceptId is null). Unmapped criteria cannot be queried and default to manual screening.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0079",
      "originalCriterionId": "EXC_10",
      "criterionType": "exclusion",
      "atomicText": "Subject is pregnant",
      "normalizedText": "Subject is pregnant",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 5.0,
        "impactScore": 0.05,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_10_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 79
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "at an unacceptably high risk for toxicities, or any subject circumstance which \nprohibits trial participation according to local law.\n10. Subject is pregnant or lactating.\n11. Subject has previously been treated with a PARP inhibitor.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 0.95,
        "reasoning": "Pregnancy status requires a real-time assessment (e.g., a current pregnancy test) at the time of screening. Historical pregnancy diagnoses are not sufficient to determine current status.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0080",
      "originalCriterionId": "EXC_10",
      "criterionType": "exclusion",
      "atomicText": "Subject is lactating",
      "normalizedText": "Subject is lactating",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 5.0,
        "impactScore": 0.05,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_10_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 80
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "at an unacceptably high risk for toxicities, or any subject circumstance which \nprohibits trial participation according to local law.\n10. Subject is pregnant or lactating.\n11. Subject has previously been treated with a PARP inhibitor.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "SCREENING_ONLY",
        "confidence": 0.95,
        "reasoning": "Pregnancy status requires a real-time assessment (e.g., a current pregnancy test) at the time of screening. Historical pregnancy diagnoses are not sufficient to determine current status.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0081",
      "originalCriterionId": "EXC_11",
      "criterionType": "exclusion",
      "atomicText": "Previously treated with a PARP inhibitor",
      "normalizedText": "Previously treated with a PARP inhibitor",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          600195086
        ],
        "conceptNames": [
          "Targeted Therapy"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (600195086)",
        "sqlExecutable": true,
        "valueConstraint": "PARP inhibitor"
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C93352",
            "display": "Targeted Therapy"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C93352",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_11_1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 81
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "at an unacceptably high risk for toxicities, or any subject circumstance which \nprohibits trial participation according to local law.\n10. Subject is pregnant or lactating.\n11. Subject has previously been treated with a PARP inhibitor.",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.95,
        "reasoning": "Targeted therapy is a class of medication with a mapped OMOP concept. It can be queried from the drug exposure domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0082",
      "originalCriterionId": "EXC_12",
      "criterionType": "exclusion",
      "atomicText": "History of another cancer",
      "normalizedText": "History of another cancer",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          600055953
        ],
        "conceptNames": [
          "Prior Invasive Malignancy"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600055953)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C154619",
            "display": "Prior Invasive Malignancy"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C154619",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_12_1a",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 82
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "11. Subject has previously been treated with a PARP inhibitor.\n12. The subject has a history of another cancer within the past 3 years except cervical \ncancer in situ, in situ carcinoma of the bladder, squamous or basal cell carcinoma \nof the skin or another in situ cancer that is considered cured by the Investigator \n(e.g., in situ prostate cancer).",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Prior Invasive Malignancy represents a historical diagnosis with a mapped OMOP concept. It can be queried from the condition occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0083",
      "originalCriterionId": "EXC_12",
      "criterionType": "exclusion",
      "atomicText": "Cervical cancer in situ",
      "normalizedText": "Cervical cancer in situ",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          198984
        ],
        "conceptNames": [
          "Malignant tumor of cervix"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (198984)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "363354003",
            "display": "Malignant tumor of cervix"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C53.9",
            "display": "Malignant neoplasm of cervix uteri, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|363354003,C53.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_12_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 83
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "11. Subject has previously been treated with a PARP inhibitor.\n12. The subject has a history of another cancer within the past 3 years except cervical \ncancer in situ, in situ carcinoma of the bladder, squamous or basal cell carcinoma \nof the skin or another in situ cancer that is considered cured by the Investigator \n(e.g., in situ prostate cancer).",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Malignant tumor of cervix is a standard diagnosis with a mapped OMOP concept. It can be queried from the condition occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0084",
      "originalCriterionId": "EXC_12",
      "criterionType": "exclusion",
      "atomicText": "In situ carcinoma of the bladder",
      "normalizedText": "In situ carcinoma of the bladder",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          35206494,
          192855
        ],
        "conceptNames": [
          "Carcinoma in situ of bladder",
          "Carcinoma in situ of urinary bladder"
        ],
        "vocabularyIds": [
          "ICD10CM",
          "SNOMED"
        ],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (35206494, 192855)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "D09.0",
            "display": "Carcinoma in situ of bladder"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "92546004",
            "display": "Carcinoma in situ of urinary bladder"
          }
        ],
        "searchParams": "code=http://hl7.org/fhir/sid/icd-10-cm|D09.0,http://snomed.info/sct|92546004",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_12_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 84
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "11. Subject has previously been treated with a PARP inhibitor.\n12. The subject has a history of another cancer within the past 3 years except cervical \ncancer in situ, in situ carcinoma of the bladder, squamous or basal cell carcinoma \nof the skin or another in situ cancer that is considered cured by the Investigator \n(e.g., in situ prostate cancer).",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Carcinoma in situ of bladder is a standard diagnosis with a mapped OMOP concept. It can be queried from the condition occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0085",
      "originalCriterionId": "EXC_12",
      "criterionType": "exclusion",
      "atomicText": "Squamous cell carcinoma of the skin",
      "normalizedText": "Squamous cell carcinoma of the skin",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4111921,
          4295624,
          4298026,
          4308621,
          45547492
        ],
        "conceptNames": [
          "Squamous cell carcinoma of skin",
          "Squamous cell carcinoma of skin of ear",
          "Squamous cell carcinoma of skin of face",
          "Squamous cell carcinoma of skin of neck",
          "Squamous cell carcinoma of skin of lip"
        ],
        "vocabularyIds": [
          "SNOMED",
          "ICD10CM"
        ],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (4111921, 4295624, 4298026, 4308621, 45547492)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254651007",
            "display": "Squamous cell carcinoma of skin"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "403894000",
            "display": "Squamous cell carcinoma of skin of ear"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "403892001",
            "display": "Squamous cell carcinoma of skin of face"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "423284006",
            "display": "Squamous cell carcinoma of skin of neck"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C44.02",
            "display": "Squamous cell carcinoma of skin of lip"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "285308002",
            "display": "Squamous cell carcinoma of skin of lower lip"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254651007,http://snomed.info/sct|403894000,http://snomed.info/sct|403892001,http://snomed.info/sct|423284006,http://hl7.org/fhir/sid/icd-10-cm|C44.02,http://snomed.info/sct|285308002",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_12_2c1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 85
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "11. Subject has previously been treated with a PARP inhibitor.\n12. The subject has a history of another cancer within the past 3 years except cervical \ncancer in situ, in situ carcinoma of the bladder, squamous or basal cell carcinoma \nof the skin or another in situ cancer that is considered cured by the Investigator \n(e.g., in situ prostate cancer).",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Squamous cell carcinoma of skin is a standard diagnosis with a mapped OMOP concept. It can be queried from the condition occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0086",
      "originalCriterionId": "EXC_12",
      "criterionType": "exclusion",
      "atomicText": "Basal cell carcinoma of the skin",
      "normalizedText": "Basal cell carcinoma of the skin",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4112752,
          4298740,
          37396458,
          37399589,
          45552253
        ],
        "conceptNames": [
          "Basal cell carcinoma of skin",
          "Basal cell carcinoma of skin of lip",
          "Nodular basal cell carcinoma of skin",
          "Basal cell carcinoma of skin in situ",
          "Basal cell carcinoma of skin of lip"
        ],
        "vocabularyIds": [
          "SNOMED",
          "ICD10CM"
        ],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (4112752, 4298740, 37396458, 37399589, 45552253)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "254701007",
            "display": "Basal cell carcinoma of skin"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "402819001",
            "display": "Basal cell carcinoma of skin of lip"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "716274007",
            "display": "Nodular basal cell carcinoma of skin"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "80071000119103",
            "display": "Basal cell carcinoma of skin in situ"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C44.01",
            "display": "Basal cell carcinoma of skin of lip"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|254701007,http://snomed.info/sct|402819001,http://snomed.info/sct|716274007,http://snomed.info/sct|80071000119103,http://hl7.org/fhir/sid/icd-10-cm|C44.01",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_12_2c2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 86
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "11. Subject has previously been treated with a PARP inhibitor.\n12. The subject has a history of another cancer within the past 3 years except cervical \ncancer in situ, in situ carcinoma of the bladder, squamous or basal cell carcinoma \nof the skin or another in situ cancer that is considered cured by the Investigator \n(e.g., in situ prostate cancer).",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Basal cell carcinoma of skin is a standard diagnosis with a mapped OMOP concept. It can be queried from the condition occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0087",
      "originalCriterionId": "EXC_12",
      "criterionType": "exclusion",
      "atomicText": "In situ cancer",
      "normalizedText": "In situ cancer",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          433435,
          1244876,
          373732,
          4116351,
          1567746
        ],
        "conceptNames": [
          "Carcinoma in situ",
          "Porocarcinoma in situ",
          "Carcinoma in situ of eye",
          "Carcinoma in situ of ear",
          "Carcinoma in situ of eye"
        ],
        "vocabularyIds": [
          "SNOMED",
          "ICD10CM"
        ],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (433435, 1244876, 373732, 4116351, 1567746)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "109355002",
            "display": "Carcinoma in situ"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "1293095009",
            "display": "Porocarcinoma in situ"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "92590009",
            "display": "Carcinoma in situ of eye"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "255144005",
            "display": "Carcinoma in situ of ear"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "D09.2",
            "display": "Carcinoma in situ of eye"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|109355002,http://snomed.info/sct|1293095009,http://snomed.info/sct|92590009,http://snomed.info/sct|255144005,http://hl7.org/fhir/sid/icd-10-cm|D09.2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_12_2d1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 87
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "11. Subject has previously been treated with a PARP inhibitor.\n12. The subject has a history of another cancer within the past 3 years except cervical \ncancer in situ, in situ carcinoma of the bladder, squamous or basal cell carcinoma \nof the skin or another in situ cancer that is considered cured by the Investigator \n(e.g., in situ prostate cancer).",
        "confidence": 1.0
      },
      "queryableStatus": "fully_queryable",
      "nonQueryableReason": null,
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Carcinoma in situ is a standard diagnosis with a mapped OMOP concept. It can be queried from the condition occurrence domain.",
        "overridable": true
      }
    },
    {
      "atomicId": "A0088",
      "originalCriterionId": "EXC_12",
      "criterionType": "exclusion",
      "atomicText": "Cancer considered cured by Investigator",
      "normalizedText": "Cancer considered cured by Investigator",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          433435,
          1244876,
          373732,
          4116351,
          1567746
        ],
        "conceptNames": [
          "Carcinoma in situ",
          "Porocarcinoma in situ",
          "Carcinoma in situ of eye",
          "Carcinoma in situ of ear",
          "Carcinoma in situ of eye"
        ],
        "vocabularyIds": [
          "SNOMED",
          "ICD10CM"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (433435, 1244876, 373732, 4116351, 1567746)",
        "sqlExecutable": false
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "109355002",
            "display": "Carcinoma in situ"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "1293095009",
            "display": "Porocarcinoma in situ"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "92590009",
            "display": "Carcinoma in situ of eye"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "255144005",
            "display": "Carcinoma in situ of ear"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "D09.2",
            "display": "Carcinoma in situ of eye"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|109355002,http://snomed.info/sct|1293095009,http://snomed.info/sct|92590009,http://snomed.info/sct|255144005,http://hl7.org/fhir/sid/icd-10-cm|D09.2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_12_2d2",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 88
      },
      "provenance": {
        "pageNumber": 37,
        "textSnippet": "11. Subject has previously been treated with a PARP inhibitor.\n12. The subject has a history of another cancer within the past 3 years except cervical \ncancer in situ, in situ carcinoma of the bladder, squamous or basal cell carcinoma \nof the skin or another in situ cancer that is considered cured by the Investigator \n(e.g., in situ prostate cancer).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "SQL template requires manual concept selection",
      "queryabilityClassification": {
        "category": "QUERYABLE",
        "confidence": 0.98,
        "reasoning": "Carcinoma in situ is a standard diagnosis with a mapped OMOP concept. It can be queried from the condition occurrence domain.",
        "overridable": true
      }
    }
  ],
  "logicalGroups": [
    {
      "qebId": "QEB_INC_1",
      "criterionType": "inclusion",
      "criterionText": "Subject must be ≥ 18 years of age.",
      "clinicalName": "Minimum Age of 18 Years",
      "atomicIds": [
        "A0001"
      ],
      "funnelStage": 4,
      "funnelStageName": "Baseline Demographics & Medical History",
      "isKiller": false,
      "queryableStatus": "fully_queryable"
    },
    {
      "qebId": "QEB_INC_2",
      "criterionType": "inclusion",
      "criterionText": "Life expectancy > 12 weeks (as per Investigator's clinical assessment).",
      "clinicalName": "Life Expectancy Greater Than 12 Weeks",
      "atomicIds": [
        "A0002"
      ],
      "funnelStage": 3,
      "funnelStageName": "Performance Status & Disease Burden",
      "isKiller": false,
      "queryableStatus": "requires_manual"
    },
    {
      "qebId": "QEB_INC_3",
      "criterionType": "inclusion",
      "criterionText": "Subject must have cytologically or histologically confirmed advanced or metastatic non-squamous NSCLC. Subjects with mixed histology tumors will be eligible if the tumor is predominant non-squamous histology and does not include tumor with small cell histology. Subjects must have a pathologist's report confirming non-squamous NSCLC available for collection by the sponsor. Subjects with EGFR mutation (exon 19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement must have progresse",
      "clinicalName": "Confirmed Advanced or Metastatic Non-Squamous NSCLC",
      "atomicIds": [
        "A0003",
        "A0004",
        "A0005",
        "A0006",
        "A0007",
        "A0008",
        "A0009",
        "A0010",
        "A0011",
        "A0012",
        "A0013"
      ],
      "funnelStage": 1,
      "funnelStageName": "NSCLC Indication & Molecular Profile",
      "isKiller": true,
      "queryableStatus": "partially_queryable"
    },
    {
      "qebId": "QEB_INC_4",
      "criterionType": "inclusion",
      "criterionText": "Subject must have NSCLC that is not amenable to surgical resection or radiation with curative intent at time of study Screening.",
      "clinicalName": "NSCLC Not Amenable to Curative Therapy",
      "atomicIds": [
        "A0014",
        "A0015",
        "A0016"
      ],
      "funnelStage": 1,
      "funnelStageName": "NSCLC Indication & Molecular Profile",
      "isKiller": false,
      "queryableStatus": "requires_manual"
    },
    {
      "qebId": "QEB_INC_5",
      "criterionType": "inclusion",
      "criterionText": "Subjects must be current smokers (defined as having > 100 smoking events lifetime and having smoked within the past year) or former smokers (defined as having > 100 smoking events lifetime and having not smoked within the past year).",
      "clinicalName": "Current or Former Smoking History",
      "atomicIds": [
        "A0017",
        "A0018",
        "A0019"
      ],
      "funnelStage": 4,
      "funnelStageName": "Baseline Demographics & Medical History",
      "isKiller": false,
      "queryableStatus": "partially_queryable"
    },
    {
      "qebId": "QEB_INC_6",
      "criterionType": "inclusion",
      "criterionText": "Subject must have at least 1 unidimensional measurable NSCLC lesion on a CT scan as defined by RECIST (version 1.1).",
      "clinicalName": "Measurable Disease by RECIST 1.1",
      "atomicIds": [
        "A0020"
      ],
      "funnelStage": 3,
      "funnelStageName": "Performance Status & Disease Burden",
      "isKiller": false,
      "queryableStatus": "requires_manual"
    },
    {
      "qebId": "QEB_INC_7",
      "criterionType": "inclusion",
      "criterionText": "Subject must consent to provide archived tissue or cytology sample of NSCLC lesion (primary or metastatic) for analysis if available.",
      "clinicalName": "Consent for Tumor Tissue Sample Provision",
      "atomicIds": [
        "A0021",
        "A0022",
        "A0023"
      ],
      "funnelStage": 6,
      "funnelStageName": "Screening Laboratory & Tissue Requirements",
      "isKiller": false,
      "queryableStatus": "requires_manual"
    },
    {
      "qebId": "QEB_INC_8",
      "criterionType": "inclusion",
      "criterionText": "Subject must have no history of brain metastases or evidence of CNS tumors at screening assessment. Subjects with signs or symptoms of CNS involvement will undergo MRI (or CT scan if MRI is contraindicated) to confirm absence of CNS metastases.",
      "clinicalName": "Absence of Brain Metastases or CNS Tumors",
      "atomicIds": [
        "A0024",
        "A0025"
      ],
      "funnelStage": 3,
      "funnelStageName": "Performance Status & Disease Burden",
      "isKiller": false,
      "queryableStatus": "partially_queryable"
    },
    {
      "qebId": "QEB_INC_9",
      "criterionType": "inclusion",
      "criterionText": "Subject must have an Eastern Cooperative Oncology Group (ECOG) Performance Score of 0 – 1.",
      "clinicalName": "ECOG Performance Status of 0 or 1",
      "atomicIds": [
        "A0026"
      ],
      "funnelStage": 3,
      "funnelStageName": "Performance Status & Disease Burden",
      "isKiller": false,
      "queryableStatus": "partially_queryable"
    },
    {
      "qebId": "QEB_INC_10",
      "criterionType": "inclusion",
      "criterionText": "Subjects with fluid retention, including ascites or pleural effusion, may be allowed at the discretion of the Investigator.",
      "clinicalName": "Fluid Retention Permitted at Investigator Discretion",
      "atomicIds": [
        "A0027",
        "A0028",
        "A0029"
      ],
      "funnelStage": 5,
      "funnelStageName": "Comorbidities & Contraindications Assessment",
      "isKiller": false,
      "queryableStatus": "partially_queryable"
    },
    {
      "qebId": "QEB_INC_11",
      "criterionType": "inclusion",
      "criterionText": "Subject must have adequate bone marrow, renal and hepatic function as follows:\n\n● Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm3 (1.5 × 109/L); Platelets ≥ 100,000/mm3 (100 × 109/L); Hemoglobin ≥ 9.0 g/dL;\n\n● Renal function: Serum calculated creatinine clearance > 50 mL/min according to the Cockcroft-Gault formula; confirmation of creatinine clearance/GFR may be done by a local direct measurement method (e.g., 24 hour urine collection or radioisotope) at the investigator's discretion;\n",
      "clinicalName": "Adequate Hematologic, Renal, and Hepatic Function",
      "atomicIds": [
        "A0030",
        "A0031",
        "A0032",
        "A0033",
        "A0034",
        "A0035",
        "A0036",
        "A0037",
        "A0038",
        "A0039",
        "A0040",
        "A0041",
        "A0042",
        "A0043"
      ],
      "funnelStage": 6,
      "funnelStageName": "Screening Laboratory & Tissue Requirements",
      "isKiller": false,
      "queryableStatus": "fully_queryable"
    },
    {
      "qebId": "QEB_INC_12",
      "criterionType": "inclusion",
      "criterionText": "Female subjects of childbearing potential (i.e., those who are not postmenopausal for at least 1 year or surgically sterile by bilateral tubal ligation, bilateral oophorectomy or hysterectomy) and their male partners should practice at least one of the methods of birth control listed below during study and for at least 6 months after treatment with paclitaxel chemotherapy. Male subjects and their female partners of childbearing potential should practice at least one of the methods of birth contr",
      "clinicalName": "Contraception Requirements for Men and Women",
      "atomicIds": [
        "A0044",
        "A0045",
        "A0046",
        "A0047",
        "A0048",
        "A0049",
        "A0050",
        "A0051"
      ],
      "funnelStage": 7,
      "funnelStageName": "Consent & Study Compliance Confirmation",
      "isKiller": false,
      "queryableStatus": "requires_manual"
    },
    {
      "qebId": "QEB_INC_13",
      "criterionType": "inclusion",
      "criterionText": "Subject must be capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consent approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures.",
      "clinicalName": "Ability to Provide Informed Consent and Comply",
      "atomicIds": [
        "A0052",
        "A0053",
        "A0054"
      ],
      "funnelStage": 7,
      "funnelStageName": "Consent & Study Compliance Confirmation",
      "isKiller": false,
      "queryableStatus": "requires_manual"
    },
    {
      "qebId": "QEB_EXC_1",
      "criterionType": "exclusion",
      "criterionText": "Subject has a known hypersensitivity to paclitaxel or to other drugs formulated with polyethoxylated castor oil (Cremophor).",
      "clinicalName": "Known Hypersensitivity to Paclitaxel or Excipients",
      "atomicIds": [
        "A0055",
        "A0056"
      ],
      "funnelStage": 5,
      "funnelStageName": "Comorbidities & Contraindications Assessment",
      "isKiller": false,
      "queryableStatus": "partially_queryable"
    },
    {
      "qebId": "QEB_EXC_2",
      "criterionType": "exclusion",
      "criterionText": "Subject has a known hypersensitivity to platinum compounds.",
      "clinicalName": "Known Hypersensitivity to Platinum Compounds",
      "atomicIds": [
        "A0057"
      ],
      "funnelStage": 5,
      "funnelStageName": "Comorbidities & Contraindications Assessment",
      "isKiller": false,
      "queryableStatus": "partially_queryable"
    },
    {
      "qebId": "QEB_EXC_3",
      "criterionType": "exclusion",
      "criterionText": "Subjects with peripheral neuropathy ≥ grade 2.",
      "clinicalName": "Significant Pre-existing Peripheral Neuropathy",
      "atomicIds": [
        "A0058"
      ],
      "funnelStage": 5,
      "funnelStageName": "Comorbidities & Contraindications Assessment",
      "isKiller": false,
      "queryableStatus": "partially_queryable"
    },
    {
      "qebId": "QEB_EXC_4",
      "criterionType": "exclusion",
      "criterionText": "Subjects with squamous NSCLC, or those with an untreated EGFR mutation (exon 19 deletion or L858R mutation in exon 21) and/or ALK gene rearrangement. Subjects' EGFR mutation and ALK gene rearrangement status must be known prior to study entry.",
      "clinicalName": "Exclusion of Squamous NSCLC or Untreated Driver Mutations",
      "atomicIds": [
        "A0059",
        "A0060",
        "A0061",
        "A0062",
        "A0063",
        "A0064",
        "A0065"
      ],
      "funnelStage": 1,
      "funnelStageName": "NSCLC Indication & Molecular Profile",
      "isKiller": false,
      "queryableStatus": "partially_queryable"
    },
    {
      "qebId": "QEB_EXC_5",
      "criterionType": "exclusion",
      "criterionText": "A history of seizure within 12 months prior to study entry.",
      "clinicalName": "History of Seizure Within 12 Months",
      "atomicIds": [
        "A0066"
      ],
      "funnelStage": 4,
      "funnelStageName": "Baseline Demographics & Medical History",
      "isKiller": false,
      "queryableStatus": "fully_queryable"
    },
    {
      "qebId": "QEB_EXC_6",
      "criterionType": "exclusion",
      "criterionText": "Subject has received prior cytotoxic chemotherapy or chemoradiotherapy for NSCLC, except adjuvant or neoadjuvant therapy > 12 months prior to C1D-2, or subject has received targeted small molecule monotherapy for EGFR and/or ALK-positive disease ≤ 14 days prior to C1D-2 or biologic therapy ≤ 21 days prior to C1D-2.",
      "clinicalName": "Prior Systemic or Radiotherapy for NSCLC",
      "atomicIds": [
        "A0067",
        "A0068",
        "A0069",
        "A0070",
        "A0071",
        "A0072"
      ],
      "funnelStage": 2,
      "funnelStageName": "Prior Anti-Cancer Therapy Review",
      "isKiller": false,
      "queryableStatus": "partially_queryable"
    },
    {
      "qebId": "QEB_EXC_7",
      "criterionType": "exclusion",
      "criterionText": "Subject has received anti-cancer Chinese medicine or anti-cancer herbal remedies within 14 days prior to C1D-2.",
      "clinicalName": "Recent Use of Anti-Cancer Herbal Remedies",
      "atomicIds": [
        "A0073",
        "A0074"
      ],
      "funnelStage": 7,
      "funnelStageName": "Consent & Study Compliance Confirmation",
      "isKiller": false,
      "queryableStatus": "requires_manual"
    },
    {
      "qebId": "QEB_EXC_8",
      "criterionType": "exclusion",
      "criterionText": "Subject has undergone focal External Beam Radiation Therapy (EBRT) to bone ≤ 2 weeks prior to C1D-2; or subject has undergone EBRT to larger fields (i.e., 100 cm² to thorax) ≤ 4 weeks prior to C1D-2.",
      "clinicalName": "Recent External Beam Radiation Therapy",
      "atomicIds": [
        "A0075",
        "A0076"
      ],
      "funnelStage": 2,
      "funnelStageName": "Prior Anti-Cancer Therapy Review",
      "isKiller": false,
      "queryableStatus": "fully_queryable"
    },
    {
      "qebId": "QEB_EXC_9",
      "criterionType": "exclusion",
      "criterionText": "Any medical condition, which in the opinion of the Investigator, places the subject at an unacceptably high risk for toxicities, or any subject circumstance which prohibits trial participation according to local law.",
      "clinicalName": "Unacceptable Risk per Investigator's Judgment",
      "atomicIds": [
        "A0077",
        "A0078"
      ],
      "funnelStage": 7,
      "funnelStageName": "Consent & Study Compliance Confirmation",
      "isKiller": false,
      "queryableStatus": "requires_manual"
    },
    {
      "qebId": "QEB_EXC_10",
      "criterionType": "exclusion",
      "criterionText": "Subject is pregnant or lactating.",
      "clinicalName": "Pregnancy or Lactation",
      "atomicIds": [
        "A0079",
        "A0080"
      ],
      "funnelStage": 7,
      "funnelStageName": "Consent & Study Compliance Confirmation",
      "isKiller": false,
      "queryableStatus": "fully_queryable"
    },
    {
      "qebId": "QEB_EXC_11",
      "criterionType": "exclusion",
      "criterionText": "Subject has previously been treated with a PARP inhibitor.",
      "clinicalName": "Prior PARP Inhibitor Treatment",
      "atomicIds": [
        "A0081"
      ],
      "funnelStage": 2,
      "funnelStageName": "Prior Anti-Cancer Therapy Review",
      "isKiller": false,
      "queryableStatus": "fully_queryable"
    },
    {
      "qebId": "QEB_EXC_12",
      "criterionType": "exclusion",
      "criterionText": "The subject has a history of another cancer within the past 3 years except cervical cancer in situ, in situ carcinoma of the bladder, squamous or basal cell carcinoma of the skin or another in situ cancer that is considered cured by the Investigator (e.g., in situ prostate cancer).",
      "clinicalName": "History of Other Malignancy Within 3 Years",
      "atomicIds": [
        "A0082",
        "A0083",
        "A0084",
        "A0085",
        "A0086",
        "A0087",
        "A0088"
      ],
      "funnelStage": 2,
      "funnelStageName": "Prior Anti-Cancer Therapy Review",
      "isKiller": false,
      "queryableStatus": "partially_queryable"
    }
  ],
  "processingMetadata": {
    "processingTimeSeconds": 214.4851520061493,
    "llmModelUsed": "gemini-2.5-pro",
    "stageInputsUsed": [
      "stage2",
      "stage11_eligibility_funnel"
    ],
    "llmWarnings": []
  }
}